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ABSTRACT
Investigating Cotranslational Integration of a Multi-spanning Membrane Protein
into the Endoplasmic Reticulum Membrane. (December 2008)
Candice Gene Jongsma, B.S.; B.S., Grand Valley State University
Chair of Advisory Committee: Dr. Arthur E. Johnson
Most membrane proteins in eukaryotic cells are co-translationally
integrated into the endoplasmic reticulum (ER) membrane at aqueous pores
termed translocons.  During multi-spanning membrane protein (MSMP)
integration, the nascent polypeptide is threaded into the translocon pore where
each successive transmembrane segment (TMS) is moved laterally through the
translocon into the bilayer.  The hydrophilic polypeptide segments on each side
of the TMS are alternately directed into either the aqueous cytosol or the
aqueous ER lumen. How is the ER membrane permeability barrier maintained
during this process?
For a single-spanning signal-cleaved membrane protein, nascent chain
movement into the lumen occurs while an ion-tight ribosome-translocon junction
prevents ion flow through the translocon pore.  Prior to opening this junction to
allow nascent chain movement into the cytosol, BiP (Hsp70 binding protein)
effects closure at the lumenal end of the pore to maintain the membrane
permeability barrier.  To determine whether the ribosome and BiP alternately
iv
mediate pore closure during the integration of a MSMP, integration
intermediates with nascent chains of different lengths were prepared with a
fluorescent probe positioned in the nascent chain far inside the ribosomal tunnel.
Nascent chain exposure to the cytosol or lumen was then detected by the
collisional quenching of the probe by iodide ions located on either the cytosolic
or lumenal side of the membrane.
While the first TMS through the tunnel caused the ribosome-translocon
junction to open, the second TMS elicited both the closure of this junction and
the opening of the lumenal end of the pore.  Movement of a third TMS through
the tunnel caused the ribosome-translocon junction to re-open after closure of
the lumenal end.  Pore opening and closing occurred after each TMS was 4-7
residues from the peptidyltransferase center, irrespective of TMS location in the
nascent chain.  The ribosome treated all TMSs in the same manner, regardless
of their individual sequence or their native orientation. The ER membrane
permeability barrier is maintained by ribosome-translocon interactions during co-
translational MSMP integration.
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1CHAPTER I
INTRODUCTION
Cells are the structural and functional building blocks of all living
organisms and fall into two general categories: prokaryotes and eukaryotes.
Prokaryotes, which include bacteria and archaea, are unicellular organisms that
are distinguished from eukaryotes on the basis of nuclear organization.
Prokaryotes lack a nucleus and other intracellular organelles that are associated
with eukaryotic cells, the eukaryotic cell (Fig. 1) is a highly organized complex of
organelles enclosed within membranes.  A defining feature of the eukaryotic cell
is the nucleus, which contains the genetic material of a cell.  Other organelles,
such as the endoplasmic reticulum (ER), Golgi apparatus, and mitochondria are
also found in eukaryotes. It has been suggested that eukaryotes evolved from
prokaryotic history about 1.6-2.1 billion years ago (Knoll, 1992).
The ER is an extensive membrane network that serves many functions
within the eukaryotic cell, including the facilitation of protein folding and the
sorting of molecules targeted for specific destinations, such as the Golgi
complex. The ER membrane is a single phospholipid bilayer that encloses an
aqueous internal compartment known as the ER lumen. The ER membrane
serves as a barrier separating the lumen from the cytoplasm. The lumen is a site
____________
This dissertation follows the style of Cell.
2Figure 1.  Eukaryotic cell. (http://www.yorku.ca/kdenning/++2140%202006-
7/2140-17oct2006.htm:  Denning, K., 2006) A eukaryotic cell is a highly
organized membrane-bound structure containing a variety of organelles
including the nucleus, ER, golgi apparatus, mitochondria, and ribosomes.
3of protein modification in the cell, where cleavage of the signal sequence by
signal peptidase (SP) and N-glycosylation by oligosaccharyltransferase (OST)
are carried out.  The lumen also functions as the primary storage location for
intracellular calcium ions (Berridge, 2002; Koch, 1990). The concentration of
calcium inside the ER lumen is several orders of magnitude greater than that in
the surrounding cytoplasm (Demaurex and Frieden, 2003). These calcium ions
function as potent second messengers when they are released from the ER
lumen into the cytoplasm.  Therefore, it is critical that the cell prevents the
unregulated release of calcium from the ER during protein translocation through
and integration into the ER membrane to avoid disrupting cell metabolism.
In eukaryotic cells, protein synthesis begins on free ribosomes that are
dispersed in the cytoplasm. Approximately 30% of all proteins found in
eukaryotic organisms are secretory or membrane proteins.  Secretory proteins
and soluble proteins localized in several organelles such as the ER lumen need
to be transported across the eukaryotic ER membrane, while membrane
proteins are inserted and integrated directly into the ER membrane. A protein
that needs to be trafficked to the ER is recognized by the presence of a signal
sequence, a short, hydrophobic stretch of amino acid residues (typically about
15-30 residues) that is usually located at the N-terminus of the polypeptide (Fig.
2). The signal sequence is bound to the signal recognition particle (SRP) upon
4Figure 2. SRP-dependent targeting to the ER membrane.
(http://nobelprize.org/nobel_prizes/medicine/laureates/1999/illpres/protein.html:
Blobel, G., 1999) SRP recognizes and binds to a signal sequence, temporarily
halting nascent chain elongation. The ribosome-nascent chain complex is
directed to the translocon through interactions between SRP and the SRP-
receptor. The ribosome engages with the translocon, SRP is released, and
nascent chain elongation continues. After translation is complete, the ribosome
disengages from the membrane and dissociates into its respective subunits.
5emerging from the ribosome, and the SRP directs the ribosome•nascent chain
complex to the ER membrane via an interaction with the SRP receptor (Walter
and Johnson, 1994). The same translocation machinery is used to handle both
soluble and membrane proteins. While protein trafficking is understood in
general terms, the mechanisms involved are not well understood at the
molecular level.
Membrane proteins play essential roles in a number of cellular functions
such as signal transduction, proton pumping, and ion transport.  Some
membrane proteins associate peripherally with the membrane, while others,
referred to as transmembrane (TM) proteins, span the entire bilayer (Fig. 3).  TM
proteins are amphipathic, meaning they contain hydrophobic and hydrophilic
regions.  The hydrophobic TM segments (TMSs) are embedded in and interact
with the nonpolar core of the bilayer, while hydrophilic sections that loop
between two successive TMSs extend into the aqueous regions located on
either side of the membrane.  TM proteins adopt particular orientations in the
membrane because the cytoplasmic domains have different functions than the
lumenal domains. TMSs that traverse the lipid bilayer fold into α helices to
maximize the extent of hydrogen bonding within the nonaqueous membrane
interior.
How are these large macromolecules able to be integrated into the ER
membrane in the proper orientation, with hydrophilic domains located on both
6sides of the membrane, without disrupting the permeability barrier and allowing
leakage of small ions?
Figure 3.  An integral membrane protein spans the phospholipid bilayer.
(http://www.biology.arizona.edu/cell_bio/problem_sets/membranes/graphics/prot
eins.jpg: Grimes, W. and Lapointe, M., 2002) Transmembrane proteins contain
hydrophobic domains that interact with the non-polar core of the bilayer and
hydrophilic domains that extend into the aqueous regions located on either side
of the bilayer.
Integral Membrane Proteins
Peripheral Membrane Protein
Lipid Bilayer
7Protein Biosynthesis
Central Dogma
Francis Crick first introduced the central dogma of molecular biology in
1958 (Crick, 1970). The genes of a cell contain genetic instructions for the two-
step synthesis of proteins.  The information encoded in genes can be converted
from DNA to RNA through a process called transcription, and from RNA to
protein through a process called translation (Fig. 4).
Transcription
Transcription is the process through which the DNA nucleotide sequence
encoding a specific protein is copied, or transcribed, into RNA.  Transcription
begins by denaturing the double stranded DNA.  The enzyme RNA polymerase
moves along the double stranded DNA, opening and unwinding a small portion
of DNA to expose the bases on the DNA strand.  A single strand of DNA serves
as the template for transcription. Incoming nucleotides are base-paired to the
template, generating a single-stranded RNA molecule, or transcript, that is an
exact complement to the template DNA strand.  While the synthesized RNA
performs a variety of functions, it is the messenger RNA (mRNA) whose base
sequence is translated into a sequence of amino acids that comprise the protein.
8Figure 4. Central dogma of molecular biology.  (http://www-
stat.stanford.edu/~susan/courses/s166/central.gif: Holmes, S., 2007) The
information contained in DNA is replicated and also transcribed into mRNA.
Ribosomes read and translate the mRNA into a protein. This figure was
downloaded from http://www-stat.stanford.edu/~susan/courses/s166/central.gif.
9Translation
The information carried in a mRNA molecule is converted into a protein
through a process called translation. The nucleotide sequence encoded by
mRNA is read and translated into a “new language”, one based on amino acids
instead of nucleotides, according to the rules of the genetic code.  The base
sequence in the mRNA molecule is read consecutively in groups of three.  Each
group of three consecutive RNA bases is called a codon and specifies a single
amino acid. The genetic code is the key for identifying the codons and is used
universally in all present-day organisms.  The code is highly degenerate and
many amino acids are identified by more than one codon.
Protein synthesis begins on free ribosomes in the cytoplasm of the cell.
The 80S ribosome found in eukaryotes is composed of a smaller 40S subunit
and a larger 60S subunit that associate during translation.  The ribosome
complex reads the mRNA in a 5’-to-3’ direction beginning with the start codon.
The mRNA nucleotide sequence is translated into an amino acid sequence
using transfer RNAs (tRNA) located in the cytoplasm.  The tRNAs contain an
anticodon that base-pairs with the codon on the mRNA chain, and this specifies
a particular amino acid for addition to the growing nascent polypeptide chain.
During translation elongation, the nascent chain is synthesized one amino acid
at a time, beginning with the N-terminal end of a protein.  The elongation cycle
continues until a stop codon is reached, thereby halting translation.  Termination
10
of translation causes the nascent polypeptide chain to be released from the
tRNA and the ribosomal complex to dissociate back into its two respective
subunits. 
During translation the newly synthesized polypeptide chain is confined
inside the ribosomal tunnel of the larger (60S) subunit. The ribosomal tunnel
holds approximately 40 amino acid residues from the C-terminal end of the
nascent chain (Blobel and Sabatini, 1970).  As translation progresses, the
nascent polypeptide chain is directed down the tunnel until the polypeptide chain
exits the ribosome. It is only after the emergence of a signal sequence from the
ribosome that the pathway of protein biosynthesis diverges from translation on
free ribosomes to translation on membrane-bound ribosomes.  The latter is the
focus of this dissertation.
Protein Trafficking
SRP-Dependent Targeting to the ER Membrane
Nearly all eukaryotic secretory and membrane proteins are
cotranslationally translocated across or integrated into the ER membrane,
respectively, at sites termed translocons (Walter and Lingappa, 1986).  These
proteins are identified by a 15-30 residue signal sequence or a signal anchor at
the N-terminus (von Heijne, 1985) that is recognized by the signal recognition
particle (SRP).  After the identifying signal sequence emerges from the
ribosome, SRP binds to the signal sequence in the nascent chain and elicits a
11
temporary arrest of nascent chain elongation (Fig. 2).  Interactions between the
SRP and the SRP receptor, which is located at the ER membrane near the
translocon, direct the SRP•RNC complex to the ER membrane (Gilmore et al.,
1982a; Gilmore et al., 1982b; Johnson and van Waes, 1999; Meyer et al., 1982;
Rapiiejko and Gilmore, 1997). SRP interacts with the SRP receptor in a GTP-
dependent manner, initiating a series of reactions in which the signal sequence
is released from the SRP, the SRP and SRP receptor move away from the
ribosome, and the ribosome engages with the translocon.  Protein synthesis is
then resumed, and the nascent chain is directed into the translocon.
Translocon Components
The translocon is the site of secretory protein translocation across and
membrane protein integration into the ER membrane (Walter and Lingappa,
1986).  The core components of the mammalian translocon are thought to be the
heterotrimeric Sec61 complex (Sec61αβγ), the translocon-associated membrane
protein (TRAM), and other translocon-associated proteins including the lumenal
Hsp70 chaperone BiP (immunoglobulin heavy-chain binding protein) and SRP
receptor (Johnson and van Waes, 1999; Nichitta and Blobel, 1990; Rapoport et
al., 1996).
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Cotranslational Translocation of a Secretory Protein
Blobel and Dobberstein first hypothesized that secretory proteins are
translocated through the ER membrane into the lumen via an aqueous channel
formed by integral membrane proteins (Blobel and Dobberstein, 1975).  This
hypothesis would be debated for nearly 20 years, until the first direct evidence
supporting nascent chain occupancy an aqueous channel would be obtained
(Crowley et al., 1994).
The secretory protein preprolactin (pPL) was used in early studies to
glean information about the structure of the translocon and the cotranslational
translocation process. Aminoacyl-tRNA analogs were used to site specifically
incorporate water-sensitive fluorescent probes into the nascent chain of pPL
during its synthesis by the ribosome (Crowley et al., 1994; Crowley et al., 1993). 
Fluorescence lifetime measurements (see Ch. II for details) of the pPL
translocation intermediates revealed that the fluorescent dye in the nascent
chain was in an aqueous milieu inside the membrane-bound ribosome and the
translocon (Crowley et al., 1994).  Collisional quenching experiments utilizing
iodide ions as hydrophilic collisional quenchers of fluorescence (see Ch. II for
details) provided an independent confirmation that the nascent chain of the
secretory protein passes through an aqueous pore in the translocon (Crowley et
al., 1994). This result provided the first direct experimental evidence that the
nascent secretory protein moves through the ER membrane via an aqueous
13
pore (Blobel and Dobberstein, 1975) rather than through the hydrophobic interior
of the bilayer (Engelman and Steitz, 1981).
Additional collisional quenching experiments revealed that an ion-tight
junction at the cytoplasmic end of the translocon pore is formed by the ribosome
binding to the ER membrane (Crowley et al., 1993). The nascent chain is
completely enclosed in an aqueous tunnel in the ribosome during cotranslational
translocation (Fig. 5).  Nascent chain movement into the cytoplasm is prevented
by the docking of the ribosome on the translocon. Thus, the only direction that
the nascent chain can move is down the ribosomal tunnel, where the nascent
chain is then directed into the aqueous pore of the translocon. The quenching
experiments also showed that the translocon pore is initially sealed at the
lumenal end and is not opened until the nascent chain reaches a length of
approximately 70 amino acids (Crowley et al., 1994).  Therefore, it is possible for
a secretory protein to be cotranslationally translocated across the ER membrane
without being unnecessarily exposed to the cytoplasm.
The identity of the lumenal seal of the translocon was investigated by
extracting all soluble lumenal proteins from microsomes and reconstituting them
with purified proteins.  These experiments revealed that BiP is both necessary
and sufficient to mediate the sealing of the lumenal end of the translocon both in
the ribosome-free state and when engaged with early translocation
14
Figure 5. Cotranslational secretory protein translocation across the ER
membrane.  The ribosome-free translocon has a diameter of ~15 Å.  A ribosome
translating a secretory protein binds to the translocon of the ER membrane,
forming an ion-tight seal.  The translocon pore expands to an ID of ~50 Å and
the secretory protein is cotranslationally translocated across the membrane.
After translation is complete, the ribosome dissociates from the membrane and
the translocon returns back to its ribosome-free state.
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intermediates (<70aa) in a nucleotide-dependent manner (Hamman et al.,
1998). The mechanism proposed for cotranslational translocation of a secretory
protein across the ER membrane is shown in Figure 5.
The molecular dimensions of the translocon pore were determined by
using collisional quenching agents of different sizes.  Quenching agents were
introduced into the interior of microsomes of intact, fully assembled translocation
intermediates using pore forming proteins to determine which agents were small
enough to enter the pore from the lumenal side and quench the fluorescence of
a nascent chain probe located inside the ribosome on the cytoplasmic side of
the ER membrane. The aqueous pore in a ribosome-bound, functioning
translocon expands to an inner diameter of 40-60 Å (Hamman et al., 1997).  In
contrast, a ribosome-free translocon was determined to be much smaller, having
an inner diameter of only 9-15 Å (Hamman et al., 1998).
Cotranslational Integration of a Single-spanning Membrane Protein
Translocation of a secretory protein required only an ion-tight ribosome-
membrane junction to maintain the permeability barrier of the ER membrane.
However, nascent membrane proteins must move TMSs laterally and allow
egress of cytosolic domains from the ribosome-translocon pore, presumably by
opening the ribosome-translocon junction without compromising the permeability
barrier.  When a TMS in a nascent chain reaches the translocon, it is retained at
the translocon instead of continuing its passage through translocon pore into the
16
lumen (Do et al., 1996; McCormick et al., 2003).  The ribosome-translocon seal
must be broken to allow the cytoplasmic domains to move into the cytosol during
cotranslational integration.  This reality then raises the question: How is the
permeability barrier of the membrane maintained during this process?
To address the mechanism of membrane protein integration at the ER
membrane, previous studies have used a fusion protein, designated 111p,
containing a pPL-derived signal sequence at the N-terminus to ensure proper
targeting, followed by a lysine free stretch of pPL, and a single TMS derived
from vesicular stomatitus G (VSVG) that is oriented Nlumenal-Ccytosolic both in the
native state and in 111p (Haigh and Johnson, 2002; Liao et al., 1997).
These experiments showed that the permeability barrier of the membrane
is maintained by sealing the lumenal end of the translocon pore while the TMS is
still far inside the ribosomal tunnel near the peptidyltransferase center (PTC)
(Liao et al., 1997). Hence, it is the ribosome, not the translocon, that first
recognizes a TMS and initiates a series of events converting the functional mode
of the translocon from translocation to integration (Fig. 6). It was subsequently
shown that BiP is responsible, either directly or indirectly, for sealing the lumenal
end of the translocon pore (Haigh and Johnson, 2002).  After the lumenal end of
the pore has been sealed, the ion-tight ribosome-translocon seal at the cytosolic
end of the pore is breached, presumably to allow the cytosolic domain of the
nascent chain access to the cytoplasm (Haigh and Johnson, 2002; Liao et al.,
1997).  By sealing the lumenal end of the pore before opening the cytosolic end,
17
Figure 6.  Cotranslational integration of a single-spanning membrane
protein into the ER membrane.  The RNC complex, containing a single TMS
(black rectangle) with a fluorescent probe (red dot) incorporated into the nascent
chain, is targeted to the translocon (yellow) during cotranslational integration.
The lumenal end of the translocon pore is sealed by BiP (pink), either directly as
depicted here or indirectly, prior to pore opening at the cytosolic end.
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the system ensures that the integrity of the ER membrane is maintained.  The
proposed mechanism for cotranslational membrane protein integration of a
single-spanning membrane protein into the bilayer is depicted in Figure 6.
How does the ribosome distinguish a nascent chain lacking a TMS and
destined for translocation from a nascent chain containing a TMS and destined
for integration into the membrane? Liao et al. (Liao et al., 1997) hypothesized
that a TMS would fold into an α-helix when a TMS interacted with a weakly non-
polar patch in the ribosomal tunnel.  Fluorescence resonance energy transfer
(FRET) was used to assess nascent chain conformation of a single-spanning
membrane protein (Woolhead et al., 2004).  The distance between an excited
fluorescent donor dye and an acceptor chromophore can be measured by the
extent of non-radiative energy transfer from the donor to the acceptor.  The
donor dye and acceptor dye were positioned on opposite sides of the TMS, and
the efficiency of FRET between the two dyes was measured. Dye separation for
a protein that is folded into an α-helix (1.5 Å per amino acid) is much less than
that of a protein in a fully extended conformation (3.5 Å per amino acid).  The
FRET results showed that a TMS in a nascent membrane protein folds into a
compact α-helix, or nearly so, when the TMS is far inside the ribosomal tunnel
near the PTC (Woolhead et al., 2004).  This folding is induced and stabilized by
the ribosome, and the TMS retains the folded conformation as it moves through
the ribosome, into the translocon, and enters into the membrane (Lin, 2008; Lin,
unpublished data; Woolhead et al., 2004).
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Additional insight was gained through photo-crosslinking studies in which
a photoreactive probe was incorporated into the nascent chain of both a
secretory and a membrane protein, and cross-linking to ribosomal proteins was
examined. The data showed that a secretory protein photo-crosslinked to only
one ribosomal protein having an apparent mass of approximately 40 kDa
(Woolhead et al., 2004).  In contrast, a single-spanning membrane protein
photo-crosslinked to three different ribosomal proteins having apparent
molecular masses of approximately 40, 18, and 7 kDa (Woolhead et al., 2004).
The ribosomal proteins are believed to be L4 (40 kDa), L17 (18 kDa), and L39 (7
kDa) in eukaryotes (Ban et al., 2000).
These photo-crosslinking interactions coincide with the structural changes
occurring at the translocon that were determined through fluorescence
quenching.  The BiP-mediated closure of the translocon pore at the lumenal end
occurred when the TMS began to photo-crosslink to L17 (Woolhead et al.,
2004).  When the ribosome-translocon junction at the cytoplasmic end of the
pore is opened, the TMS is then photo-crosslinked to L39 (Woolhead et al.,
2004).
Based on the data obtained through TMS-dependent FRET, photo-
crosslinking, and fluorescence collisional quenching experiments, a mechanism
for the communication between the ribosome, nascent chain, and translocon has
been proposed (Fig. 7).  A weakly nonpolar surface in the ribosomal tunnel
nucleates the folding of a TMS into a compact α-helix (or nearly so). This
20
Figure 7.  Large ribosomal subunit.  The large ribosomal subunit is shown
here.  Both secretory and membrane proteins photo-crosslinked to L4.
Membrane proteins also photo-crosslinked to L17 and L39. Reprinted with
permission from Cell: (Woolhead et al., 2004), copyright Elsevier 2004.
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appears to occur when the folded TMS reaches the tip of L17 in the nascent
chain tunnel, and this in turn probably elicits a conformational change in L17 that
extends to its domain located at the surface of the ribosome near the translocon.
L17 then presumably interacts with a membrane-spanning protein, and this
interaction triggers the BiP-mediated sealing of the lumenal end of the pore.  As
then nascent chain moves down the tunnel, the folded TMS next encounters the
L39 protein.  Interactions between the TMS and L39 result in the opening of the
cytoplasmic end of the pore.
An Alternative Model Based on Cryo-EM and Crystal Structures
Despite the supporting evidence (Alder and Johnson, 2004; Crowley et
al., 1994; Crowley et al., 1993; Haigh and Johnson, 2002; Hamman et al., 1997;
Hamman et al., 1998; Liao et al., 1997; Woolhead et al., 2004), controversy still
surrounds the mechanism by which the permeability barrier of the ER membrane
is maintained (Rapoport, 2007; Rapoport et al., 2004). Cryoelectron microscopy
(cryo-EM) studies have always detected a small “gap”, estimated to be as large
as 20 Å (Beckman et al., 1997; Menetret et al., 2000) or as small as 12 Å
(Osborne et al., 2005), between the translocon and the ribosome (Beckman,
2001; Morgan et al., 2002).  It has therefore been inferred by these authors that
the presence of a gap shows the ribosome does not form an ion-tight seal with
the translocon as indicated by the fluorescence collisional quenching studies.
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Based on a single crystal structure of a monomeric archaeal
SecYEβ complex, an alternative model was described in detail in the reviews
from Osborne et al., 2005 and Rapoport, 2007.  In these models, ion flow is
minimized due to a constriction in the translocon pore. The pore is purported to
be formed from a single copy of the SecYEβ (which is presumably homologous
to the mammalian Sec61 complex) (Osborne et al., 2005; Rapoport, 2007; van
den Berg et al., 2004), that has an hour-glass shape with hydrophilic funnels on
both sides of the constriction (Fig. 8).  One funnel is exposed to the cytosol and
the other funnel is sealed at the lumen by a short, helical “plug”.  The diameter of
the pore ring in the crystal structure is thought to be too small for a polypeptide
chain to pass through, so presumably the pore has some flexibility (Gumbart and
Schulten, 2006; Haider et al., 2006; Saparov and al., 2007; Tian and Andricioaei,
2006) that allows it to expand at some point during translocation to
accommodate the polypeptide chain.  It is postulated that the insertion of the
signal sequence into the translocon could force the translocon pore to widen to
the appropriate size necessary to accommodate the polypeptide chain.  When
the polypeptide is being actively translocated through the pore “The pore ring
would fit like a gasket around the translocating polypeptide chain, thereby
restricting the passage of small molecules during protein translation.  The seal
would not be expected to be perfect…Leakage is probably compensated for by
powerful ion pumps.” (quoted text taken from Rapoport, 2007).  The insertion of
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Figure 8. Cross-sectional view of a closed translocon channel.  The pore is
depicted having an hour-glass shape with a constriction in the center of the pore
and a hydrophilic funnel at either end. The plug (in yellow) is in the center of the
α-subunit.  The pore-ring residues are shown in green. Reprinted with
permission from Nature Reviews: (Rapoport, 2007), copyright Macmillan
Publishers Ltd 2007.
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the signal sequence would also destabilize plug interactions, causing the plug to
move from the center of the pore into a cavity at the back of the molecule,
thereby allowing the polypeptide to traverse the entire length of the pore.
The opposing views on ER membrane permeability that contrast so
dramatically with the fluorescence studies may simply be explained by
differences in samples that were examined.  High-resolution crystal and cryo-EM
studies require a detergent treatment to solubilize the translocon away from the
membrane.  Therefore, the samples used in the cryo-EM studies are lacking all
lipids and also some translocon and translocon-associated proteins, such as
TRAM.  It is possible that the ribosome may not be able to form a seal with the
translocon in the absence of these components. The crystal structure was also
determined in the absence of the ribosome, the membrane, and translocon-
associated proteins.  Here, the crystal structure may not accurately represent
the structure of an intact, fully-assembled and functional RNC•translocon
complex.  In stark contrast to the cryo-EM and crystal studies, the fluorescence
collisional quenching experiments were performed using fully-assembled and
intact samples maintained in aqueous solution under native conditions, thereby
preserving the integrity of the translocons.
There are other discrepancies surrounding the interpretations of the cryo-
EM and x-ray data as well.  While one paper (van den Berg et al., 2004) and
many reviews argue that the translocon pore is formed from only a single Sec61
complex, other papers (including some from the above labs) argue that the pore
25
is located at the interface of three or four complexes (Beckman et al., 1997;
Beckman, 2001; Breyton et al., 2002; Manting et al., 2000; Morgan et al., 2002).
There are also conflicting reports regarding the number of linkages connecting
the ribosome to the translocon, with as few as one (Beckman et al., 1997) and
as many as seven (Menetret, 2005) having been reported.  In addition, the
reported size of the gap observed between the ribosome and the translocon has
shrunk from 20 Å (Menetret et al., 2000) to 12 Å (Osborne et al., 2005). Despite
all of these uncertainties, these low resolution [15.4 Å (Beckman, 2001) to 27 Å
(Menetret et al., 2000)] cryo-EM images have been used to develop detailed
models that purport to explain the conformations and changes that occur to a
functional translocon during translocation and membrane protein integration.
Specific Aims of This Dissertation
How is the permeability barrier of the ER membrane maintained when a
MSMP containing both lumenal and cytosolic domains is threaded into the
nonpolar bilayer during cotranslational integration?  Previous work performed in
this lab has shown that a single-spanning membrane protein elicits a series of
changes at the translocon to maintain the barrier.  The synthesis and movement
of a single TMS into the ribosomal tunnel effected pore closure at the lumenal
end of the pore, followed by pore opening at they cytosolic end.  What is the
gating mechanism when multiple TMSs are present?
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Here I have used a fluorescence-based technique to directly and
unambiguously examine the exposure of the nascent chain to the cytosol and
the lumen at several different stages during the cotranslational integration of a
MSMP into the ER membrane.  In addition, several different TMSs were
characterized to assess whether the ribosome recognizes length, sequence,
hydrophobicity, and/or orientation during MSMP integration.  While the first TMS
results in pore opening at the cytosolic end of the pore, a second TMS reverses
the gating process and results in pore opening at the lumenal end.  The
ribosome and translocon respond to a third TMS in the same manner as the first,
closing the lumenal end and opening the cytosolic end of the pore.  Thus, the
translocon pore is alternately opened and closed as sequential TMSs of a
MSMP are synthesized and moved into the translocon and membrane.  At any
given time during translation an ion-tight seal is maintained at one end of the
pore, thereby ensuring that integrity of the membrane is always maintained.
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CHAPTER II
METHODS AND MATERIALS
Plasmids and Mutagenesis
The plasmids used in this work were based on the original 111p construct
that has been described in detail previously (Do et al., 1996; Liao et al., 1997).
Plasmids containing multiple transmembrane segments with varying lengths of
nascent chain between adjacent TMSs were prepared by and obtained from Dr.
Peter McCormick.  Site-directed mutagenesis was performed when necessary to
add, delete, or move the lysine codon to a desired position in the protein.
Desalted and lyophilized DNA primers were designed using Vector NTI
software and synthesized commercially by Integrated DNA Technologies, Inc
(IDT) or Sigma Genosys.  The primers were resuspended in double distilled
water (ddH2O) to a final concentration of 250 ng/µL.  A typical PCR was
performed in a total volume of 50 µL and contained 2.5 units Pfu Turbo DNA
polymerase (Stratagene), 1x of the included corresponding Pfu buffer
(Stratagene), 200 µM final concentration of dNTPs (Takara), 125 ng each of
forward and reverse primer, 1 ng of plasmid DNA, and ddH2O.
PCR reactions were carried out using a GeneAmp PCR System 9700
thermocycler.  The reaction was first heated to 95°C for 30 s followed by 18
cycles of denaturing at 95°C for 30 s, annealing at 55°C for 60 s, and elongation
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at 68°C for 10 min.  A final extension for 5 min at 68°C and cooling to 4°C
completed the program.
Following PCR, a Dpn1 (Promega) digestion was performed to digest the
parental DNA template. PCR product (25 µL) was combined with 2 µL of Dpn1
and 3 µL of Dpn1’s corresponding Buffer B (comes with the Dpn1).  After the
mixture was incubated at 37°C for 1.5 hr, 25 µL of the product was added to 100
µL of Top-10 competent E. coli. cells and incubated on ice for 10 min.  A heat
shock at 42°C for 60 s was performed, and then the sample was rapidly
transferred back to ice for an additional 2 min.  Next, 400 µL of LB media was
added to the sample and the sample was incubated at 37°C for 1 hr on a shaker
at 225 rpm.  Then the culture was spread onto an LB ampicillin (40 mg/L) plate
and incubated overnight at 37°C.  Individual colonies were picked and placed in
5 mL of LB ampicillin agar and incubated overnight at 37°C, 225 rpm.  The
following day a pellet was prepared by centrifuging 1.5 mL of the mixture in a 1.5
mL microfuge tube for 3 min at 13000 rpm. The supernatant was aspirated, and
the procedure was repeated one more time so that a total of 3 mL culture was
used to form the pellet.  Finally, the plasmid DNA was purified by following the
procedures given in the Qiagen Mini-prep Quick Kit (cat # 27106) for use with a
microcentrifuge.  The plasmids were sequenced at the Gene Technologies
Laboratory (Department of Biology, TAMU).  The primers that were used to
make the single-site mutations used in this dissertation are given in Table 1.
29
Table 1.  Primers for site-directed mutagenesis.
Primer Sequence Mutation Other Notes
FP212N28K
CCCGTCTGTCCCAAAGGGCCTG
GCAAC
N28K Complements RP212N28K
RP212N28K
GTTGCCAGGCCCTTTGGGACAG
ACGGG
N28K Complements FP212N28K
FP212K101N
CTACATCCTGCTCAACCTGGCC
GTGGCC
K101N Complements FP212K101N
RP212K101N
GGCCACGGCCAGGTTGAGCAGG
ATGTAG
K101N Complements RP212K101N
FP353KG144KA
GCCACCTTGGGCAAAGAAATTG
CACTG
AAG to AAA Complements RP353KG144KA
RP353KG144KA
CAGTGCAATTTCTTTGCCCAAGG
TGGC
AAG to AAA Complements FP353KG144KA
FP2TML41D99K
CCCACTACATCCATAAACTCTCC
TCGGAAATG
D99K Complements FP2TML41D99K
RP2TML41D99K
CATTTCCGAGGAGAGTTTATGGA
TGTAGTGGG
D99K Complements RP2TML41D99K
FP2TML41Q110K
GTTCAACGAATTTGATAAACGGT
ATGCAACGGGCCAAGGG
Q110K Complements RP2TML41Q110K
RP2TML41Q110K
CCCTTGGCCCGTTGCATACCGTT
TATCAAATTCGTTGAA
Q110K Complements FP2TML41Q110K
FP2TML41N124K
CATTACCATGGCCCTCAAAAGCT
GCCATACCCGGCTG
N124K Complements RP2TML41N124K
RP2TML41N124K
CAGCCGGGTATGGCAGCTTTTG
AGGGCCATGGTAATG
N124K Complements FP2TML41N124K
FP343L65KGKA
GCTTCTTTGCCACCTTGAAAGGT
GAAATTGCACTGTG
AAG to AAA Complements RP343L65KGKA
RP343L65KGKA
CACAGTGCAATTTCACCTTTCAA
GGTGGCAAAGAAGC
AAG to AAA Complements FP343L65KGKA
FPVSVG2I139K
CTGCGCAGACCCCTCAAGTCTA
AAGCAAGC
I139K Complements RPVSVG2I141K
RPVSVG2I139K
GCTTGCTTTAGAGTTGAGGGGT
GTGCGCAG
I139K Complements FPVSVG2I141K
FPTM2TM1I150K
GCAAGCTTTTTCTTTATCAAAGG
CCTGATCATTGGAC
I150K Complements RPTM2TM1IK
RPTM2TM1I150K
GTCCAATGATCAGGCCTTTGATA
AAGAAAAAGCTTGC
I150K Complements FPTM2TM1IK
FPOVK70I
GCTACATCCTGCTCATACTGGCC
GTGGCCGACC
K70I Complements RPOVK70I
RPOVK70I
GGTCGGCCACGGCCAGTATGAG
CAGGATGTAGC
K70I Complements FPOVK70I
FPOVK150N
GCAAGCTTTTTCTTTATCAACGG
CCTGATCATTGGAC
K150N Complements RPOVK150N
RPOVK150N
GTCCAATGATCAGGCCGTTGATA
AAGAAAAAGCTTGC
K150N Complements FPOVK150N
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The PCR-based method described in detail by van den Ent and Lowe
(van den Ent and Lowe, 2006) was used to move TMSs in their entirety to first
create a construct containing two identical TMSs (TM1L53TM1) and then to
create a construct where the order of the TMSs has been reversed
(TM2L53TM1).
First, a PCR was set up containing a final concentration of 1x Ex TaqTM
polymerase buffer Taq (Takara), 0.2 mM dNTPs (Takara), 2.5 u/µL ExTaq DNA
polymerase (Takara), and 1 ng DNA plasmid 2TML52K2.  The forward primer 5’-
CTGCAGCTGCGCACACCCCTCAACTCTATTGCAAGCTTTTTCTTTATCATAG
GC-3’ and the reverse primer 5’-GACGAAGTATCCGTGCAGAGAGGTGA
GAACCAAGAATAGTCCAATGATCAGGCC-3’ were added to final
concentrations of 1 pmol/µL.  The final volume was diluted to 50 µL using
ddH2O. Samples were first denatured for 2 min at 94°C. Then a cycle was
repeated 30 times where samples were denatured for 30 s at 94°C, annealed for
30 s at 60°C, and elongated for 40 s at 72°C.  A final extension at 72°C for 5 min
followed by sample cooling to 4°C completed the PCR program. PCR products
were purified using a QIAquick PCR Purification Kit (Qiagen cat # 28106).
Purified PCR DNA was eluted in 30 µL of EB elution buffer (from kit).
A second PCR was set up containing a total volume of 50 µL.  This PCR
included 2.5 units Pfu Turbo DNA polymerase (Stratagene), 1x of the
corresponding Pfu buffer (Stratagene), and 200 µM final concentration of dNTPs
(Takara).  Approximately 100 ng of purified PCR product from the previous PCR
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and 1 ng of DNA plasmid 2TML53K2 were added and the reaction was diluted to
final volume using ddH2O.  Samples were denatured for 30 s at 95°C. A cycle
consisting of denaturing for 30 s at 95°C, annealing for 60 s at 55°C, and
elongating for 10 min at 68°C was repeated 35 times.  After a final extension at
68°C for 5 min, the sample was cooled to 4°C to complete the PCR. The Dpn1
digestion and transformation were carried out exactly as previously described for
site-directed mutagenesis, and the identity of the resulting plasmid was
confirmed by sequencing at the Gene Technologies Laboratory (Department of
Biology, TAMU).
The plasmid containing two TMSs whose order has been reversed
(TM2L53TM1) was prepared using the same PCR based method that has just
been described.  The first PCR contained the forward primer 5’-
GAAATGTTCAACGAACTCGACAGGAGCTACATCCTGCTCAAACTGGCCGTG
GCCGAC-3’ and its complement 5’-CATGACTGCCCGCCGGAATTCTCGG
TCGAGGGTGGTGGTGAAGCCCCCGAAGACC-3’.  All other experimental
conditions remained the same.  The second PCR was identical to that previously
described except that the newly made plasmid TM1L53TM1 was used in place of
2TML53K2.  The resulting plasmid was TM2L53TM1 and the identity was
confirmed by sequencing.  The primers used were synthesized commercially
and PAGE-purified by IDT or Sigma Genosys.
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PCR-generated Translation Intermediates
PCR was performed using a 5’-primer designed to include the start
methionine and the SP6 promoter region and 3’-primers designed to generate
DNA products of specified lengths. Primers were 20-30 base pairs in length and
synthesized commercially by IDT.  Table 2 gives the primers used for PCR to
generate intermediates of varying lengths.  A typical PCR was performed in a
total volume of 50 µL.  Ex TaqTM polymerase buffer Taq (Takara) and 2.5 mM
dNTPs (Takara) were added to final concentrations of 1x and 0.2 mM,
respectively.  The forward and reverse primers were added to a final
concentration of 1 pmol/µL each.  The template DNA was added to a final
concentration of 1 ng/µL.  ExTaq DNA polymerase (Takara) was added to a final
concentration of 2.5 u/µL.  The total reaction volume was obtained by adding
ddH2O.
 PCR samples were first denatured for 2 min at 94°C. Then a cycle where
samples were denatured for 30 s at 94°C, annealed for 30 s at 60°C, and
extended for 40 s at 72°C was repeated 30 times.  A final extension at 72°C for
5 min followed by sample cooling to 4°C completed the PCR program.
PCR products were purified using a QIAquick PCR Purification Kit
(Qiagen cat # 28106).  Purified PCR DNA was eluted in 30 µL of EB elution
buffer (from kit).  Confirmation of successful PCR was obtained by running 5 µL
of PCR product on a 1.6% (w/v) agarose/TAE [40 mM Tris-acetate and 1mM
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Table 2.  Primers for PCR-generated DNA fragments of different lengths.
Primer Sequence Template Purpose
1335-EC
CCCAGTCACGACGTT
GTAAAACG
Any Forward Primer
RP111
ACAAGCTCGCGCAAT
TAACCCTC
Any Reverse Primer
2TML12-122
CAGAGAGGTGTAGAG
GGTGGTGGTG 2TML12K2 2TML12K2122
1450-CJ
GAAGTATCCGTGCAG
AGAGGTGTAGAG 2TML12K2 2TML12K2126
1459-CJ
GGGCCCAAAGACGAA
GTATCC 2TML12K2 2TML12K2130
2TML12-148
ACCTGAATCGTTACG
GTCGACACTAG 2TML12K2 2TML12K2148
2TML12-160
GTTGTTGTAATCAAC
CACCATGGAGC 2TML12K2 2TML12K2160
1451-CJ
CAGAGAGGTGTAGAG
GGTGGTGGTG 2TML53K2 2TML53K2163
1452-CJ
GTATCCGTGCAGAGA
GGTGTAGAGGG 2TML53K2 2TML53K2166
1459-CJ
GGGCCCAAAGACGAA
GTATCC 2TML53K2 2TML53K2171
1.5TML53-163
CAGGTTGCAGCCCGT
GGGCC 2TML53K1.5 2TML53K1.5163
1.5TML53-166
GAAGCCCTCCAGGTT
GCAGC 2TML53K1.5 2TML53K1.5166
1.5TML53-171
GTCGACACTAGTAAA
GAAGCCCTCCAG 2TML53K1.5 2TML53K1.5171
TM1TM1-159
CAGAGAGGTGAGAAC
CAAGAATAGTCC TM1L53TM1K TM1L53TM1159
TM1TM1-162
GTATCCGTGCAGAGA
GGTGAGAACC TM1L53TM1K TM1L53TM1162
TM1TM1-167
GGGCCCAAAGACGAA
GTATCCG TM1L53TM1K TM1L53TM1167
TMTM1-91
GAATTCTCGGTCGAG
GGTGGTGG TM2KL53TM1 TM2L53TM191
TMTM1-94
TGCCCGCCGGAATTC
TCGGTA TM2KL53TM2 TM2L53TM194
TMTM1-99
GTGGGACACCATGAC
TGCCCG TM2KL53TM3 TM2L53TM199
TM1TM1-159
CAGAGAGGTGAGAAC
CAAGAATAGTCC TM2L53TM1K TM2L53TM1163
TM1TM1-162
GTATCCGTGCAGAGA
GGTGAGAACC TM2L53TM1K TM2L53TM1166
TM1TM1-167
GGGCCCAAAGACGAA
GTATCCG TM2L53TM1K TM2L53TM1171
1462-CJ
GTACCGCTCGATGGC
CAGGAC 3TML12,17K3 3TML12,17K3159
1463-CJ
CACCACCACGTACCG
CTCGAT 3TML12,17K3 3TML12,17K3162
1464-CJ
GTCGACACTAGTGCA
CACCACCAC 3TML12,17K3 3TML12,17K3167
1462-CJ
GTACCGCTCGATGGC
CAGGAC 3TML12,67K3 3TML12,67K3209
1463-CJ
CACCACCACGTACCG
CTCGAT 3TML12,67K3 3TML12,67K3212
1464-CJ
GTCGACACTAGTGCA
CACCACCAC 3TML12,67K3 3TML12,67K3217
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EDTA (pH 8.0)] gel containing ethidium bromide (10 mg/mL) under a constant
voltage of 120 Volts.
Preparation of Lys-tRNALys
Yeast Lys-tRNALys and εNBD-Lys-tRNALys were purified and prepared by
Yuanlong Shao and Yiwei Miao as previously described in detail (Crowley et al.,
1993, Johnson et al., 1976). The extent of NBD modification of the side chain
amino group of lysine in εNBD-Lys-tRNALys was determined by paper
electrophoresis (Johnson et al., 1976).
In vitro Transcription
Typically, a 100 µL in vitro transcription reaction consisted of 20 µL DNA
(see above) and the following reagents added to the final concentrations
specified: 80 mM HEPES (pH 7.5); 16 mM Mg(OAc)2; 2 mM Spermidine; 10 mM
DTT; 3 mM each of ATP; CTP, UTP, and GTP; 0.5 mM Diguanosine
Triphosphate [GpppG] (Amersham); 0.5 units / µL RNasinTM (Promega); 3 µL
purified SP6 RNA polymerase; 0.005 units / µL Pyrophosphatase.  Samples
were incubated at 37°C for 90 min.  Then an additional 3.2 µL of 100 mM GTP
was added, and samples are incubated for an additional 40 min.  After the
incubation was complete, the RNA was precipitated by adding 13.3 µL of 3 M
NaOAc (pH 5.2) and 340 µL of 100% ethanol.  Samples were incubated on ice
for a minimum of 1 hr.  Samples were spun at 4°C for 20 min at 14,000 rpm in a
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Beckman Coulter microfuge.  The supernatant was aspirated and the pellets are
washed with 1 mL of 70% (v/v) ethanol.  Samples were spun for an additional 10
minutes at 4°C, the supernatant was aspirated, and the pellets were dried on a
speed vac for 30 minutes.  The dry pellets were resuspended in 100 µL of TE
Buffer [10 mM Tris-HCl (pH 7.5)/ 1 mM EDTA (pH 7.5)]. The homogeneity of the
transcription products was confirmed on a 1.8 % agarose/TAE gel. The prepared
mRNA was frozen using liquid nitrogen and stored at  -80°C for future use in in
vitro translations.
In vitro Translations
Proteins were synthesized by in vitro translation in the presence of SRP
and salt-washed ER microsomes (KRMs).  The total translation volume for
collisional quenching experiments was 500 µL.  The translation mixture was
prepared in a 1.5 mL microfuge tube and included the following: 100-130 mM
KOAc (pH 7.5) (optimize); 20 mM HEPES (pH 7.5); 3.0-3.5 mM Mg(OAc)2
(optimize); 1 mM DTT; 0.2 mM Spermidine; 8 µM SAM (S-Adenoysyl-
Methionine); 1 X protease inhibitors (PIN); 0.2 units/µL RNasin (Promega); 2 µM
EGS-K/EGS-M (energy generating system containing 375 µM of each of the 20
amino acids with the exception of lysine (K) or methionine (M), 120 mM creatine
phosphate, and 0.12 units/µL creatine phosphokinase); 60-80 µL (optimize)
wheat germ (WG); 40 nM SRP; 80 eqs KRMs; 40 µL mRNA; and 300 pmol
εNBD-Lys-tRNALys or [14C]Lys-tRNALys.
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The SRP and KRMs were prepared in-house as described before (Walter
and Blobel, 1983).  The WG was prepared as previously described (Erickson
and Blobel, 1983). For translations which would be analyzed by SDS-PAGE,
EGS lacking methionine (EGS-M) was sometimes instead of EGS-K, and 0.1
µCi/µL [35S]methionine was also added. The protease inhibitors (PIN) were
prepared in a 200x stock as already described (Erickson and Blobel, 1983).
Before the addition of the mRNA, tRNA, and the [35S]-Met when necessary, the
reaction was incubated at 26°C for 7 min to allow for unlabeled translation of any
endogenous mRNAs. After the addition of the mRNA and tRNA, reactions were
incubated at 26°C for 40 minutes. When working with longer nascent chain
lengths (171 amino acid residues and longer), the mRNA and tRNA were not
added until after the translation had proceeded for 5 min.
Trichloroacetic Acid Precipitation
The in vitro translations were routinely analyzed by hot trichloroacetic acid
(TCA) precipitation to quantify the amount of acid-precipitable radioactivity in a
sample.  Typically, a 2 µL aliquot of translation mixture was mixed with 1 mL of
10% (w/v) TCA/ 3% (w/v) casamino acids (CAA) in a 13 x 100 mm glass test
tube.  The sample mixture was then incubated at 85°C for 10 min and
subsequently cooled on ice for an additional 2 min.  The heating hydrolyzed any
RNA molecules while precipitating the polypeptides.   The samples were
vortexed and filtered under vacuum through a 25 mm Metricel nitrocellulose
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membrane filter (45 um pore size, Gelman Sciences) that had been prewashed
with 3 mL cold 5% (w/v) TCA.  The precipitate on the filter was washed with 3
mL cold 5% (w/v) TCA a total of three times prior to drying.  The filters were
dried under a heat lamp for 10 min, resuspended in PPO/POPOP/toluene
scintillation cocktail, and counted in a liquid scintillation counter (Beckman).
SDS-PAGE
The translation products were resolved by SDS-PAGE using gels that were
14 cm high x 19 cm wide x 0.8 mm thick.  The stacking portion of the gel was
prepared with 4% polyacrylamide, 60 mM Tris-HCl (pH 6.8), 0.1% (w/v) SDS,
360 mM sucrose, 0.05% (v/v) N, N, N’, N’-tetramethylethylenediamine (TEMED),
and 0.08% (w/v) ammonium persulfate (APS).  The resolving gel, containing a
10-15% (w/v) linear gradient of polyacrylamide, was made using 400 mM Tris-
HCl (pH 8.8), 0.08% (w/v) SDS, 0.02% (v/v) TEMED, and 0.08% (w/v) APS
mixed with a stock solution (Biorad) of 30% (w/v) acrylamide / 0.8% (w/v)
bisacrylamide. All reagents were obtained from Sigma unless noted.
Samples were prepared for electrophoresis by resuspension in sample
buffer containing 120 mM Tris-base, 3.6% (w/v) SDS, 7.5 mM EDTA, 125 mM
DTT, 15% (v/v) glycerol, and a small amount of bromophenol blue.  The samples
were heated for 5 min at 95°C, and then briefly centrifuged to collect the sample
in the bottom of the microfuge tube. The gel was submerged in running buffer
containing 50 mM Tris-HCl (pH 8.8), 400 mM glycine, and 0.1% (w/v) SDS.
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Twenty µL aliquots of each sample were then loaded into wells located in the
stacking portion of the gel and having the dimensions 2 cm high x 0.5 cm wide x
0.8 mm thick. The gel was run at a constant current of 15 mA for 40 minutes
during which time the samples moved through the stacking portion of the gel,
followed by a constant current of 30 mA for 2 hours and 20 minutes while the
samples moved through the resolving portion of the gel.
After the run was completed, the gel was placed in a destaining solution
containing 10 % (v/v) glacial acetic acid and 35% (v/v) methanol.  The gel was
destained for a minimum of 20 minutes.  After destaining, the gel was rinsed with
water for 10 minutes to remove the acetic acid.  Then the gel was placed on a
piece of 3MM paper (Whatman) and dried for 40 minutes at 80°C in the gel
dryer.  The dried gel was taped inside a cassette and exposed to a
phosphorimaging screen (Kodak) for a minimum of one night.  The image of the
gel was visualized using a phosphorimager (Pharos FX Plus Molecular Imager,
BioRad) and a corresponding software package (Quantity One version 4.6.5,
BioRad).
Carbonate Extraction
The standard method to determine whether a protein has been integrated
into a membrane is to perform an alkaline carbonate extraction (Fujiki et al.,
1982).  If a protein is insoluble in alkaline buffers (pH 11.5), the protein is
considered to be membrane-integrated.
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After translation, samples were spun through a sucrose cushion buffer as
described earlier.  Samples were resuspended in 100 mM Na2CO3 (pH 11.5).
Samples were then incubated on ice for 30 min.  After incubation the samples
were sedimented through an alkaline cushion buffer [0.5 M sucrose/ 100 mM
Na2CO3(pH 11.5)] at 4°C, 100,000g for 20 min in a TLA 100 rotor using a
Beckman Optima TL Ultracentrifuge.  The membrane pellet and supernatant
fractions were separated and analyzed by SDS-PAGE.
Preparation for Fluorescence Measurements
To perform collisional quenching experiments and lifetime measurements,
MSMP integration intermediates were generated by in vitro translation using the
conditions described above.  Each experiment required two reactions.  The first
reaction, designated the “sample”, was performed in the presence of  εNBD-
[14C]Lys-tRNALys.  The second reaction, termed the “blank”, was performed in
the presence of unmodified [14C]Lys-tRNALys.  After translation was complete
samples were treated with a high salt wash (or sometimes a Proteinase K (ProK)
and/or nuclease treatment) prior to sample purification by gel filtration
chromatography to remove unincorporated fluorphores and improperly targeted
material.
A high salt wash was performed to remove adsorbed salt-sensitive NBD-
containing material from the integration intermediate before the intermediate
moves into Buffer A.  Gel filtration columns were pre-loaded with 2 mL of high
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salt Buffer A (500 mM KOAc (pH 7.5)/ 20 mM HEPES/ 3.2 mM Mg(OAc)2).  After
translation was complete, additional KOAc was added to the integration
intermediates to a final concentration of 500 mM.  The reactions were incubated
on ice for 10 min before being loaded onto the gel filtration columns.
Some samples received a more stringent treatment after translation was
complete.  Instead of receiving a high salt wash, some samples were treated
with ribonuclease, followed by proteinase K, as described next.
Polysome formation was minimized in some samples by performing a
nuclease treatment that cleaved mRNA that were not protected by ribosomes,
degrading polysomes to monosomes (Wolin and Walter, 1988). Staphylococcus
aureus ribonuclease (100 units) and 1 mM CaCl2 were added to samples at the
conclusion of the translation incubation, and the samples were incubated for
another 10 min at 26°C.
An optional protease treatment to digest polypeptides exposed to the
cytosol could be performed using Proteinase K (ProK, Sigma).  The ProK was
added in a ratio of 20 µg ProK per 1 mL translation, and samples were
incubated on ice for 20 min. PMSF was added to a final concentration of 1 mM
to quench the ProK, and samples were incubated on ice for an additional 20
min.
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Gel Filtration Chromatography
Gel filtration chromatography was used to purify integration intermediates.
Typically, a 500 µL translation incubation was loaded onto a Sepharose CL-2B
(Sigma Aldrich) gel filtration column [0.7 x 50 cm (BioRad)] equilibrated at 4°C
with buffer A.  The flow rate was approximately 2-3 drops per minute, and 11-12
drop fractions containing approximately 550 µL were collected in 13 x 100 mM
glass test tubes using a fraction collector (Gilson FC 203B). The sepharose CL-
2B was replaced regularly, typically after every 4 experiments, to ensure that the
samples continued to be well purified.  Proper pouring of the column could be
visually assayed by loading a mixture containing blue dextran and potassium
ferricyanide onto the column.  The mixture separates into two colors, blue and
yellow, when run over a properly poured column.  The nascent
polypeptide•ribosome•membrane complexes were eluted in the void volume.
The fractions containing the RNC complexes were identified by measuring the
light scattering at λex 468 nm and λem 485 nm. Two fractions, giving a total
sample volume of approximately 1.1 mL, were pooled together for use in the
collisional quenching experiments.
Steady-state Fluorescence Spectroscopy
Fluorescence measurements were made on an SLM Aminco 8100
spectrofluorometer using a 450 watt xenon arc lamp as the light source.  The
excitation light passed through a double monochromator to reach the samples
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housed in a chamber cooled to 4°C using a water bath.  Nitrogen was flushed
through the chamber to prevent condensation from forming on the walls of the
quartz 4 mm x 4 mm microcuvettes (Starna Cells, Inc.).  A single emission
monochromator and a Peltier-cooled PMT housing completed the instrumental
setup.
To eliminate any background signal and light scattering when measuring
the observed NBD fluorescence intensity, readings of both the sample and the
blank were taken using an excitation wavelength of 468 nm and an emission
wavelength of 485 nm with a 4nm bandpass.  Five successive 5-second
integrations of emission intensity were recorded and averaged to give the
emission intensity. The sample with the higher reading was diluted using buffer
A until the same emission intensities for both the sample and the blank were
obtained at 485 nm.  Samples were allowed to equilibrate to 4°C for 5 min
before any measurements were obtained.
Collisional Quenching of NBD with Iodide Ions
Aliquots (250 µL) of both the sample and blank were placed into 4
microcuvettes, designated S0-S4 and B0-B4 respectively.  The NBD emission
intensity was measured using excitation and emission wavelengths of 468 nm (4
nm bandpass) and 530 nm (4 nm bandpass), respectively, for all of the cuvettes.
The initial net NBD emission intensity (F0) was obtained by subtracting the blank
signal from the sample signal (S0 - B0, etc.).
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Next, each cuvette was given an equal volume (10 µL), but differing
concentration, of iodide ions.  The final KI concentrations after addition to the
cuvettes ranged from 0 to 38 mM.  The KI was diluted using KCl to maintain a
constant ionic strength.  The reducing agent Na2S2O3 was added to the KI stock
to a final concentration of 2 mM, before diluting with KCl, to minimize I2
formation.  The cuvettes were thoroughly mixed, equilibrated to temperature,
and the net NBD emission intensity (F) was again measured.  Melittin was then
added to each cuvette as described below, and the fluorescence intensities were
measured for a third time.
The data obtained during the examination of the steady-state collisional
quenching of NBD fluorescence were analyzed using the Stern-Volmer equation.
The extent of fluorescence quenching is dependent upon the number of
collisions, and hence is directly proportional to the concentration of quencher as
described by the Stern-Volmer equation:
(F0/F) – 1 = KSV [Q] = kqτ0 [Q]    (1)
where F0 is the initial net fluorescence intensity in the absence of iodide ions, F
is the net emission intensity in the presence of quencher, kq is the bimolecular
quenching constant, τ0 is the lifetime of the fluorophore in the absence of
quencher, and [Q] is the concentration of quencher.  The Stern-Volmer constant,
KSV, equals kqτ0.  A linear least-squares best-fit graphical analysis of the data in
which the line was constrained to go through the origin (0, 0) was performed to
determine the slope (KSV), which is proportional to the extent of quenching.
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Melittin Treatment
The honey bee toxin melittin (Sigma) was used to induce pore formation
in the ER membrane.  Melittin (MLT) was diluted using ddH2O, divided into 50
µL aliquots (enough for 1 quenching experiment), and stored at -80°C until ready
for use. MLT was added to each sample to a final concentration of 5 µM and
mixed thoroughly. The samples were incubated for 30 min at room temperature
in the dark before being equilibrated to 4°C in the SLM cuvette turret and
subsequent measurement of the net fluorescence emission intensity. The
addition of MLT to the samples had no effect on targeting, translocation, or
signal peptidase activity, nor did it affect the spectral characteristics of the
fluorescent translocation intermediates (Alder et al., 2005).
Time-resolved Fluorescence Spectroscopy
Time-resolved fluorescence lifetimes were measured using an ISS model
K2 multifrequency phase fluorometer.  NBD samples were excited using a 470
nm laser diode.  The NBD emission was filtered using a 495 nm cut-on filter.
Fluorescein reference standard (Molecular Probes cat # F-1300) dissolved in 0.1
M NaOH was used for the reference, and the reference lifetime was set to 4.05
ns. The concentration of fluorescein was adjusted to have an emission intensity
similar to that of the biochemical samples to be investigated. The phase and
modulation data were analyzed using Vinci multidimensional fluorescence
spectroscopy analysis software.  The background-subtracted data were fit to
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several different models to determine which model provided the simplest fit while
still yielding a low χ2 value.  Typically, the best fit was obtained with two decay
components with two discrete exponential fits. The fit of the data to the model
was not improved by assuming the samples contained three components with
distinguishable lifetimes, nor by using a Lorentzian fit instead of a discrete fit.
The relative mole fractions of NBD probes with two different lifetimes was
calculated from the preexponential factors.
Biochemical Analysis of Fluorescent Samples
After each fluorescence experiment was completed, the sample
radioactivity was measured using a liquid scintillation counter to determine the
amount of εNBD-[14C] Lys present.  Typically, 400 µL of sample was placed in a
5 mL insert vial. A triton-based scintillation cocktail (4 mL) was added, the vial
was vortexed, and the 14C counts per minute (cpm) were measured.  The ratio of
the net NBD emission intensity in pulses per second (pps) to the number of NBD
probes in the sample in cpm was determined and expressed as the pps/cpm
ratio.
Alternatively, 400 µL of sample was sedimented through 400 µL of
sucrose cushion buffer (0.5 M sucrose/ 100 mM KOAc (pH 7.5)/ 20 mM HEPES
(pH 7.5)/ 3.2 mM Mg(OAc)2) for 7 min at 100,000 rpm and 4°C using a TLA
100.2 rotor and a Beckman Optima TL Ultracentrifuge.  The supernatant was
removed and put into an insert vial as described above.  The pellet was
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resuspended in 400 µL Buffer A, transferred to an insert vial, and the 14C cpm
that remained associated with the ribosome•nascent chain complex were
determined as described above.
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CHAPTER III
SYNTHESIS OF A SECOND TRANSMEMBRANE SEGMENT
REVERSES THE TRANSLOCON GATING MECHANISM
Experimental Design
A homogenous population of fully assembled integration intermediates
was prepared by in vitro translation, in the presence of SRP and ER
microsomes, of mRNAs that were selectively truncated in the coding region (Fig.
9).  There is no stop codon, so normal termination of translation does not occur
and the nascent chain remains bound to the ribosome as peptidyl-tRNA (Do et
al., 1996; Krieg et al., 1989).  A fluorescent probe was incorporated into the
nascent chain by performing the translation in the presence of εNBD-Lys-tRNA,
a fluorescent-labeled analog of Lys-tRNA that contains a 6-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)aminohexanoyl (NBD) dye covalently attached to the Nε-amino
group of the lysyl side chain (Crowley et al., 1994; Crowley et al., 1993).  Thus,
an NBD-labeled lysine residue was incorporated into the nascent chain at the
position of an in-frame lysine codon in the mRNA.  Incorporation of the NBD
probe into the nascent chain does not interfere with translation or SRP targeting
and processing of the nascent chain (Crowley et al., 1993).  The location of the
fluorescent probe relative to the ribosome and ER membrane is dictated by the
location of the incorporated lysine residue and the length of the nascent chain.
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Various stages of the integration process can be studied by altering the length of
the nascent chain.
Figure 9.  Integration intermediates have a single length of nascent chain.
Various lots of mRNA (mRNA were prepared on different dates and stored at
-20°C) were translated in the presence of SRP and ER microsomes to generate
integration intermediates having a single length of nascent chain.  Lanes 1, 2,
and 3 are 2TML53K2171.  Lanes 4 and 5 are 3TML12,17K3167.
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Membrane Proteins Used in This Study
Chimeric multi-spanning membrane proteins (MSMP) that contain a
single lysine codon were used in this study (Fig. 10).  The chimeric proteins
111p and 111+O2p have been well characterized previously (Liao et al., 1997;
McCormick et al., 2003), and they served as the templates for the constructs
used in this study. All proteins contained a preprolactin (pPL) derived cleavable
signal sequence to ensure that the first transmembrane segment (TMS) has type
I (N-lumenal/C-cytosolic) orientation. The first TMS is the same as the single
TMS from vesicular stomatitus viral G (VSVG) except where noted. The MSMPs
also contained one or two additional TMSs from bovine opsin, with varying
lengths of nascent chain separating adjacent TMSs. A fragment of the S.
cerevisiae invertase sequence containing three N-linked glycosylation sites was
located immediately after the last TMS, and the remainder of the protein
originally came from the proto-oncogene product Bcl-2 (Do et al., 1996).
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Figure 10.  MSMP integration intermediates. The chimeric proteins used in
this study are depicted to show the location of the preprolactin-derived signal
sequence (SS), the TM domain from vesicular stomatitus G (VSVG), the second
and/or third TM domains from opsin (OP2 and OP3, respectively), and the
location of the single lysine codon (circle).
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The following nomenclature has been used to specify the nascent chain
used in an experiment: 2TML12K2122, where 2TM denotes the presence of two
TMSs (TM1 is VSVG and TMS2 is Opsin2), L12 indicates a 12-residue loop
between adjacent TMSs, K2 indicated the lysine codon (and hence probe) is
located in TMS2, and 122 is the length of the nascent chain.
In most of the proteins used in this study, the TMSs are oriented in their
native orientation after translation and release into the membrane bilayer.
However, constructs TM1L53TM1 and TM2L53TM1 contain TMSs in their non-
native orientations.  Two identical VSVG TMSs are present in TM1L53TM1, so
the second TMS is oriented opposite to the native VSVG orientation.  The
TM2L53TM1 contains the second TMS from opsin, followed by the VSVG TMS,
so each of these TMSs are oriented opposite to their native orientations in the
membrane.  Even though the TMSs were not in their native orientation, when
these two proteins were translated in the presence of SRP and ER microsomes,
both proteins were integrated into the membrane in an N-lumenal/C-cytosol
orientation as determined by carbonate extraction and Endo H treatment (Fig.
11).
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Figure 11. The integration of TM2L53TM1 and TM1L53TM1.
The integration and orientation of (A) TM2L53TM1 and (B) TM1L53TM1 in the
membrane are shown.  Full length mRNA were translated in the presence of
SRP and ER microsomes, then processed prior to SDS-PAGE.  The proteins are
efficiently integrated into the membrane as shown by their insolubility in alkaline
buffer (pH 11.5) (compare lanes 3 and 4).  The C-termini are located in the
lumen as shown by glycosylation of the invertase domain (compare lanes 1 and
2).
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Collisional Quenching of NBD
 Nascent chain accessibility to the cytosol and the lumen was assessed
by measuring the fluorescence emission intensity of NBD in the presence of
hydrophilic collisional quenchers.  Iodide ions are efficient collisional quenchers
of NBD (Crowley et al., 1993) and were used for the experiments presented
here.  Collisional quenching occurs when a quenching agent, such as an iodide
ion, collides with a fluorophore in the excited state, and the excited state energy
is lost without emitting a fluorescent photon.  The intensity of fluorescence
emitted by the sample is therefore reduced by such collisions. The extent of
fluorescence quenching is dependent upon the number of collisions, and hence
is directly proportional to the concentration of quencher, as described by the
Stern-Volmer equation: (F0/F) – 1 = Ksv [Q], where F0 is the initial net fluorescent
intensity, F is the net emission intensity in the presence of the quencher, and [Q]
is the concentration of quencher.  The Stern-Volmer constant, Ksv, is equal to
kqτ0, where kq is the bimolecular quenching constant and τ0 is the lifetime of the
fluorophore in the absence of quencher.  Graphical analysis using this equation
will yield a linear function in which the slope (KSV) is proportional to the extent of
quenching.  Hence, a larger KSV value is indicative of increased quenching.
The accessibility of the nascent chain to the cytosol was determined by
adding iodide ions to the cytosol and directly monitoring the fluorescence
intensity of the NBD probe (Fig. 12).  If the nascent chain was exposed to the
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Figure 12.  Collisional quenching of fluorescence.  (A) The initial
fluorescence emission intensity of the probe located in the nascent chain is
measured. (B) The emission is monitored after iodide ions are added to the
cytosol to assess nascent chain exposure to the cytosol. (C) Iodide ions are
introduced into the lumen through MLT-dependent pores formed in the
membrane to assess nascent chain exposure to the lumen.
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cytosol, a decrease in fluorescence intensity would be observed due to
collisional quenching. If a ribosome-translocon junction prevented cytosolic
iodide ions from accessing the nascent chain probe (Fig. 12B), collisional
quenching would not be observed because iodide ions are not able to penetrate
the hydrophobic core of the membrane (Cranney et al., 1983). The inability of
cytosolic iodide ions to collisionally quench the fluorescence of the nascent
chain probe would infer that the nascent chain was not exposed to the cytosol.
If the cytoplasmic end of the translocon pore is sealed by an ion-tight
ribosome-translocon junction, then one would expect the lumenal end of the
pore to be open to allow nascent chain entry into the lumen. Nascent chain
exposure to the lumen was assessed by introducing iodide ions into the lumen
and measuring the fluorescence intensity of the probe (Fig. 12C).  The cytolytic
peptide Melittin (MLT) was used to create pores in the ER membrane, thereby
allowing iodide ions to enter the microsomes (Alder et al., 2005). Lumenal iodide
ions restricted to the aqueous phase, yet are able to move through the
translocon pore and into the ribosomal tunnel to quench the probe (Alder et al.,
2005; Crowley et al., 1994; Haigh and Johnson, 2002; Hamman et al., 1997;
Liao et al., 1997).  Probes that were not previously quenched because they were
not accessible to the cytosol would now be quenched if they were exposed to
the aqueous environment of the lumen.
We typically compare the extent of fluorescence quenching observed
before and after the addition of MLT.  When an ion-tight ribosome-translocon
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seal is formed at the cytoplasmic end of the translocon pore, the extent of
quenching will differ + MLT.  When the translocon pore is sealed lumenally, the
extent of quenching + MLT is the same. Therefore, the presence or absence of
MLT-dependent quenching reveals directly whether or not the ribosome is
forming an ion-tight junction with the translocon.
The MLT-induced pore (Fig. 13), having an inner diameter of 25-30 Å
(Katsu et al., 1988; Ladokhin et al., 1997), has been described as a barrel-stave
model (Naito et al., 2000; Sansom, 1991; Vogel and Jahnig, 1986).  MLT
peptides, which form an amphiphilic alpha-helix when associated with the
membrane (Matsuzaki et al., 1997), aggregate and insert into the lipid bilayer so
that the hydrophobic regions align with the lipid core and the hydrophilic peptide
regions form the interior of the of the pore (Brogden, 2005).  This peptide-
induced loss of permeability barrier is believed to be responsible for the cytolytic
activity of MLT (Matsuzaki et al., 1997). MLT-induced formation of pores in the
lipid bilayer is utilized during the collisional quenching experiments to introduce I-
into the microsomes.
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Figure 13.  The barrel-stave model of MLT-induced pore formation.
Amphiphilic peptides aggregate and insert into the lipid bilayer. The hydrophilic
region (red) forms the interior of the pore while the hydrophobic region (blue)
associates with the core of the bilayer. Reprinted by permission from Nature
Reviews Microbiology: (Brogden, 2005), copyright Macmillan Publishers Ltd
2005.
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The Fluorescence Lifetime of NBD Does Not Vary with Respect
to Its Location in the Ribosomal Tunnel
A factor that could contribute to observing different KSV values in different
collisional quenching experiments is a variation in the lifetime (τ) of the NBD dye
caused by differences in the environment of the nascent chain probe.  NBD is a
water-sensitive fluorophore that has a lifetime of approximately 1 ns in an
aqueous milieu and approximately 8 ns in a nonpolar environment (Crowley et
al., 1993; Ramachandran et al., 2004).  Since the KSV is equal to kqτ, any
change in the lifetime of the NBD dye will have a direct effect on the observed
KSV.  In order to determine whether such differences occurred, the fluorescence
lifetime of NBD incorporated into the second TMS of 2TML12K2 (Fig. 10) was
measured at different locations in the ribosomal tunnel. The data are shown in
Table 3.
The background-subtracted data were fit to several different models to
determine which model provided the simplest fit while still yielding a low χ2
value.  Typically the best model contained two decay components with two
discrete exponential fits.  Assuming the samples contained three components
with distinguishable lifetimes did not improve the fit of the data to the model.
The relative mole fractions of NBD probes in the two different environments
were determined from the preexponential factors.  Thus, the best-fit lifetime data
indicated the presence of two lifetime components in each sample, the first
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Samples were prepared as described in Ch. II.  The combined fluorescence data
from 3 independent experiments were analyzed and fit to a two-component
model in which each component was a discrete exponential decay with the
indicated lifetime (τ) and molar ratio.  χ2 values were calculated as described
previously (Jameson et al., 1984).
aData obtained from two independent experiments.
Table 3.  Fluorescence lifetimes of NBD in MSMPs. 
MSMP τ1 (ns) Molar Ratio 1 τ2 (ns) Molar Ratio 2 χ
2
2TML12K2122 2.8 0.57 8.9 0.43 12
2TML12K2130 2.7 0.61 9.3 0.39 8
2TML12K2148 2.6 0.59 9.5 0.41 3
2TML12K2160
a 2.6 0.56 9.4 0.44 7
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component having a shorter lifetime synonymous with a more aqueous
environment, and the second component having the longer lifetime expected of
a more nonpolar environment. This two component lifetime for NBD has
previously been observed with nascent secretory proteins (Crowley et al., 1994),
nascent membrane proteins (Liao, unpublished data; Lin, unpublished data), and
mitochondrial proteins (Alder and Johnson, 2008). εNBD-Lys has a single
component lifetime of 1.4 ns in an aqueous buffer (Crowley et al, 1993), but
when the dye is incorporated into a nascent chain and purified away from the
ribosome and membrane, a two component lifetime, with 80-90% being a short
lifetime synonymous with an aqueous environment, is observed (Crowley et al,
1993; Lin, unpublished data). While the origin of the 2-component NBD lifetime
is still uncertain, the data in Table 3 indicate that the second component arises
when the dye is incorporated into a polypeptide, and hence is a function of being
in a protein polymer.
All of the samples yielded similar lifetime values and molar ratios for both
the aqueous and the nonpolar components (Table 3).  Because there were no
significant differences in the average lifetimes of NBD for different lengths of
nascent chain, the KSV values observed are believed to be the result of nascent
chain exposure to and collisional quenching by iodide ions, not from changes in
the nascent chain environment.
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Some Nascent Chains with Multiple TMSs Are Not Properly
Engaged with the Translocon
Some NBD quenching by cytosolic iodide ions is observed in the absence
of MLT for samples containing long nascent chains with multiple TMSs.  As a
result, these samples have larger “-MLT” quenching than has been observed
with secretory proteins (Alder et al., 2005; Crowley et al., 1994; Crowley et al.,
1993; Hamman et al., 1997; Hamman et al., 1998). What are some possible
explanations for the increased quenching in MSMP samples when compared to
secretory proteins?
The observed -MLT quenching most likely originates from a variety of
factors including polysome formation (Hamman et al., 1997), adsorption of non-
targeted nascent chains to the outside of the membrane (Hamman et al., 1997),
and dissociation of properly targeted ribosome•nascent chain complexes
(RNCs) from the translocon (Crowley et al., 1994).  Each of these effects will
expose NBD-labeled nascent chains to the cytosol.  If these possibilities are
indeed the reasons for the significant –MLT quenching, the residual quenching
should be minimized by performing a limited protease and ribonuclease
treatment on the samples prior to purification by gel filtration chromatography, as
was previously observed when working with pPL (Hamman et al., 1997).  Any
nascent chains that were not properly targeted to the translocon, but were
instead adsorbed to the cytoplasmic surface of the microsome, should be
digested by proteinase K (ProK) added to the cytosol. A limited ribonuclease
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treatment will degrade any present polysomes to monosomes. The nuclease
cleaves mRNA that is not protected from exposure by the ribosome (Wolin and
Walter, 1988).  RNCs that were properly targeted to the translocon remain
bound to the membrane and can now be purified away from those improperly
targeted RNCs that are located in the cytoplasm.
When a combination of a limited protease and ribonuclease treatment
was performed on samples containing membrane bound RNCs (2TML53K2171,
Fig. 10), more than 50% of the –MLT quenching was eliminated.  The observed
KSV resulting from quenching by cytosolic I
- in the absence of MLT decreased
from 2.2 M-1 with no protease and ribonuclease treatment to 0.9 M-1 after such a
treatment (Fig.14 compare A with B, Table 4). This combination of treatments
was able to substantially reduce the KSV value observed in the absence of MLT,
inferring that the increased –MLT quenching seen when working with long
nascent chains containing multiple TMSs is due to the adsorption of improperly
targeted nascent chains to the outside of the membrane, polysome formation by
translating ribosomes, and the dissociation of properly targeted RNCs from the
membrane.
Since exposing a sample to either nuclease or protease carries the risk of
damaging the samples, most of my samples were not subjected to a limited
protease and nuclease treatment. Instead, I focused on the magnitude of the
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Figure 14. Iodide ion quenching of 2TML53K2171 integration intermediates.
Samples containing NBD-labeled 2TML53K2171 (A) and 2TML53K2171 after limited
protease and nuclease treatment (B) were prepared and purified as described in
Ch II. Iodide ion quenching was assessed using constant-ionic strength
procedures.  The membrane-bound integration intermediates were examined
both before ( ) and after ( ) the addition of MLT (5 µM final concentration). The
data shown are the average of 3-6 independent experiments.
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The KSV values shown are the average of 3-6 independent experiments.  The
standard deviations for the KSV values were + 0.1-0.3 M
-1.  Samples were
prepared as described in Ch. II.
Table 4.  Iodide ion quenching of NBD-labeled MSMP integration
 intermediates containing two TMSs separated by a long loop.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
2TML53K2163 3.1 3.4 0.3
2TML53K2166 1.8 4.0 2.2
2TML53K2171 2.2 4.2 2.0
2TML53K2171 (PK + nuc) 0.9 3.3 2.4
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difference in quenching (ΔKSV) observed with nascent chain exposure to
cytosolic and lumenal iodide ions (+ MLT). The observed ΔKSV values for treated
and untreated samples remained the same within error (Table 4). This approach
allowed me to compare the exposure of sample NBDs to I- in the presence and
absence of MLT. Since adding MLT to a sample will only increase the quenching
if some dyes are exposed to the lumen instead of the cytosol, the ΔKSV is a
measure of the number of nascent chain NBD dyes facing the lumen instead of
the cytosol. Thus, when the NBD probes in the nascent chain are exposed to the
cytoplasm, the observed ΔKSV will be approximately 0 M
-1.
TMS2-dependent Closing and Opening of Opposite Ends
of the Translocon Pore
A type I signal-cleaved, single-spanning membrane protein containing a
single VSVG TMS was previously studied in detail using fluorescence
spectroscopy and photocross-linking (Haigh and Johnson, 2002; Liao et al.,
1997).  After RNC targeting to the ER microsome was completed, the ribosome
formed an ion-tight seal with the translocon (Fig. 6), and the nascent membrane
protein was exposed to the lumen (Liao et al., 1997).  When the nascent chain
increased in length by two additional residues an intermediate state was
observed where both cytosolic and lumenal gates were closed, and the nascent
chain probe was no longer accessible from either side of the membrane.  The
ribosome-membrane junction then opened to expose the probe to the cytosol
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after the nascent chain had increased in length by several more residues.  The
closing of the lumenal gate and the opening of the translocon to the cytosol were
both effected while the nascent chain length increased by only 5 residues (Liao
et al., 1997). The Hsp70 chaperone BiP was required to seal the lumenal end of
the translocon pore, either directly or indirectly, in an ATP-dependent reaction
(Alder et al., 2005; Haigh and Johnson, 2002).  After termination of protein
synthesis, the translocon returned back to its ribosome-free state and the
membrane protein was fully integrated into the ER membrane.  These results
suggested that it was the ribosome, not the translocon, that first recognized a
TMS and distinguished between nascent secretory and membrane proteins.
Clearly, the mechanism by which the permeability barrier of the ER membrane is
maintained is very precise because these significant conformational changes
occurred while the nascent chain was extended by only 5 residues.
What happens when a second TMS is synthesized and moves into the
ribosomal tunnel? Does the ribosomal seal with the translocon re-form after
TMS2 enters the tunnel?  If yes, will the lumenal end of the then pore re-open to
allow egress of the lumenal domain into the ER lumen?  To investigate these
questions, collisional quenching experiments were performed using a construct
previously described in detail (McCormick et al., 2003) containing two TMSs to
assess the nascent chain exposure to the cytosol and the lumen at various
stages during the co-translational integration of a MSMP into the ER membrane.
The fusion protein, designated 2TML12K2 (Fig. 10), consists of a pPL derived
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cleavable signal sequence, a TMS from VSVG, and the second TMS from
bovine opsin, with a 12 residue stretch between the adjacent TMSs (McCormick
et al., 2003).  Since a single lysine codon is located in the mRNA in TMS2, a
single fluorescent probe is incorporated into TMS2 in a nascent chain.
If the ribosomal end of the pore that opened after the synthesis of the first
TMS continues to remain open, then cytosolic iodide ions should still be able to
access the nascent chain (Fig. 15A), and collisional quenching should be
observed.  If the ribosome re-engages with the translocon after the synthesis of
TMS2 to form an ion-tight seal (Fig. 15B), then the nascent chain will not be
exposed to iodide ions located in the cytosol and quenching should not be seen.
When the nascent chain of 2TML12K2 was 122 amino acid residues in
length, the fluorescence intensity of the probe located in TMS2 was measured
before and after the addition of cytosolic iodide ions to determine the “-MLT” KSV
(Table 5).  At this length, the C-terminal end of TMS2 is located in the ribosomal
tunnel only 3 residues away from the peptidyl transferase center (PTC).  Since
the fluorescence signal was maximally quenched by the externally added
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Figure 15.  Two possible configurations to maintain the ER membrane
permeability barrier during MSMP cotranslational integration.  (A) The
ribosome (blue) – translocon (yellow) junction at the membrane (grey) is open
and BiP (pink) seals the lumenal end of the pore.  (B) The ribosome forms an
ion-tight seal with the membrane and the lumenal end of the pore is open.
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cytosolic iodide ions without adding MLT (Fig. 16A), the nascent chain must be
accessible to the cytosol because iodide ions do not penetrate the hydrophobic
bilayer (Cranney et al., 1983; Crowley et al., 1994). The data suggest that the
ion-tight junction between the ribosome and the translocon that had opened after
the synthesis and movement of TMS1 into the ribosomal tunnel (Liao et al.,
1997) remains open immediately after the synthesis and movement of TMS2
into the tunnel.
The nascent chain was then extended in length by four additional
residues to a total length of 126 amino acids (2TML12K2126), and the NBD
fluorescence was again monitored to ascertain the effect of cytosolic iodide ions
on NBD intensity.  When the C-terminal end of TMS2 was located 7 residues
from the PTC, the extent of quenching was not maximal, but was instead
approximately equivalent to the nuclease and protease sensitive quenching
discussed earlier (p. 61). This quenching, therefore, presumably results from I-
colliding with nascent chains in polysomes or released from the RNC and
adsorbed to the microsomal surface.  The NBD probes quenched upon addition
of MLT must therefore be located within the ribosomal tunnel of an RNC with a
tight ribosome-translocon junction, where they can be quenched by lumenal I-,
but not cytosolic I-.  These nascent chains are therefore no longer exposed to
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The KSV values shown are the average of 3-4 independent experiments.  The
standard deviations for the KSV values were + 0.1-0.3 M
-1.  Samples were
prepared as described in Ch. II.
Table 5.  Iodide ion quenching of NBD-labeled MSMP integration
 intermediates containing two TMSs separated by a short loop.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
2TML12K2122 2.8 3.2 0.4
2TML12K2126 2.0 4.0 2.0
2TML12K2130 1.9 3.9 2.0
2TML12K2148 1.7 4.2 2.5
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Figure 16.  Iodide ion quenching of 2TML12K2 integration intermediates.
Samples (A) 2TML12K2122 and (B) 2TML12K2126 were prepared and purified as
described in Ch II. Iodide ion quenching was assessed using constant-ionic
strength procedures.  The membrane-bound integration intermediates were
examined both before ( ) and after ( ) the addition of MLT (5 µM final
concentration).  The data shown are the average of 3 independent experiments.
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 the cytosol (Fig. 16B, Table 5).  After the addition of MLT formed pores in the
ER membrane that allowed iodide ions to be introduced into the lumen,
maximum quenching was then observed (Fig. 16B).  The MLT-dependent ΔKSV
of 2.0 M-1 (Table 5) therefore demonstrated that approximately one half of the
NBD probes were exposed to the lumen and not the cytosol. (The other half are
largely or solely NBDs in nascent chains that are not properly engaged at the
translocon, since they are susceptible to removal with protease and/or
nuclease.) Since the nascent chain was no longer exposed to the cytosol, the
ribosome must have re-formed the ion-tight seal with the translocon. In addition,
the lumenal end of the pore must have reopened because lumenal iodide ions
were able to move through the translocon and into the ribosomal tunnel to
collide with the NBD probe far inside the ribosomal tunnel. The nascent chain
then maintained this conformation protected from the cytosol and exposed to the
lumen, as the TMS2 probe moved down the tunnel and into the translocon
(Table 5, 2TML12K2130 and 2TML12K2148).
These data suggest that the synthesis and movement of a second TMS
into the ribosomal tunnel elicits structural changes with BiP and the ribosome
that cause the ribosome to re-form a seal with the translocon and the lumenal
gate of the pore to re-open.  These changes occur only after TMS2 has moved
4-7 amino acids away from the PTC because collisional quenching by cytosolic
iodide ions was observed when the nascent chain was 122 residues in length,
but was not observed when the nascent chain was 126 residues long.
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This gating sequence is plausible for several reasons.  First, it would
seem that the lumenal end of the translocon pore would need to be re-opened at
some point during the integration process in order to allow the newly
synthesized lumenal domain of the MSMP entry into the lumen.  Second, the
cytosolic end of the translocon would presumably need to be sealed before the
lumenal end of the pore was opened to ensure that the integrity of the ER
membrane was maintained. Third, increasing nascent chain length by only 5
residues was sufficient to cause the lumenal end of the translocon to close and
the ribosomal end to open when the first TMS entered the ribosomal tunnel (Liao
et al., 1997). Therefore, it is reasonable that the reversal of the conformational
changes when a second TMS enters the ribosomal tunnel also occurs while 4-7
residues are added to the nascent chain. Fourth, the synthesis of a second TMS
triggers the re-formation of the ribosome-translocon junction because when only
one TMS was present, a nascent chain 130 residues in length remained
exposed to the cytosol (Liao et al., 1997).  When two TMSs were present, a
nascent chain of the same length (2TML12K2130) was no longer exposed to the
cytosol and was instead accessible to the lumen (Table 5).
The Lumenal End of the Translocon Pore Maintains an Ion-tight Seal
When the Cytoplasmic End of the Pore Is Open
So far we have assumed that when the cytosolic end of the pore is open,
the lumenal end is sealed to maintain the integrity of the ER membrane.  In
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order to verify that the lumenal end of the pore is indeed sealed, quenching
experiments were performed using a derivative of 2TML12 denoted 2TML12KN
(Fig. 10).  Instead of the fluorescent probe being located in TMS2, the probe was
incorporated after the signal sequence at residue 28, which was located in the
lumen of membrane-bound RNCs at longer nascent chain lengths.  If the
lumenal end of the translocon pore were indeed sealed when the cytosolic end
is open, the dye located in the lumen should not be exposed to cytosolic iodide
ions and no quenching should be observed.  After the addition of MLT to induce
pore formation in the membrane, iodide ions would then be able to enter the
lumen and collisionally quench the emission of the probe. Since we have just
shown that the ribosome-translocon junction is breached when 2TML12K2 is 122
residues long (Fig.16A), we will use a nascent chain length of 122 to determine
whether the lumenal end of the pore is closed.
When iodide ions were added to the cytosol of an 2TML12KN122, the
fluorescence of the dye located in the lumen was not quenched by the ions (Fig.
17). But, after MLT-induced pore formation in the membrane, the dye located in
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Figure 17. Iodide ion quenching of a nascent chain probe in the lumen,
2TML12KN122 integration intermediate. The integration intermediate
2TML12KN122, containing a single lysine codon at residue 28 of the nascent
chain, was prepared and purified as described in Ch. II. Iodide ion quenching
was assessed using constant-ionic strength procedures.  The membrane-bound
integration intermediates were examined both before ( ) and after ( ) the
addition of MLT (5 µM final concentration). The data shown are the average of 2
independent experiments.
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the lumen was quenched, giving a ΔKSV of 2.6 M
-1 (Fig. 17). Since the nascent
chain probe inside the ribosome is quenched by cytosolic I- in 2TML12K2122 (Fig.
16A), the cytosolic end of the pore is open. Iodide ions are therefore prevented
from moving into the lumen by BiP-mediated closure of the lumenal end of the
pore and/or a BiP-dependent constriction of the diameter of the aqueous
translocon pore. Thus, the lumenal end of the translocon pore is indeed closed
when the cytosolic end is open, thereby maintaining the permeability barrier of
the membrane.
Cytosolic Pore Closure Occurs Irrespective of TMS
Location in the Nascent Chain
Since cytosolic pore closure is effected by a second TMS moving down
the ribosomal tunnel, what effect does the length of nascent chain adjoining two
TMSs have on pore closure?  Will a longer nascent chain loop separating TMS1
and TMS2 interfere with the ribosome’s ability to close the cytosolic end of the
translocon pore?  When the TMSs were separated by a short loop, the seal
between the ribosome and the translocon remained open immediately after the
synthesis and movement of TMS2 down the tunnel (Table 5, 2TML12K2122).  One
explanation for this may be that a separation of only 12 amino acids does not
allow adequate time for the changes to occur at the translocon.  By extending
the loop separating the TMSs, the ribosome and translocon will have more time
to initiate and complete any conformational changes that are required.
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To assess the effect of nascent chain loop length on pore
opening/closing, the collisional quenching experiments that were performed
using 2TML12K2 were repeated using 2TML53K2 (Figure 10). The two proteins
differ only in the number of residues separating the adjacent TMSs; 2TML53K2
contains a nascent chain loop that is 53 residues long instead of the shorter, 12-
residue loop in 2TML12K2. In order to provide the most direct comparison
between the two constructs, we chose to focus on three different nascent chain
lengths in which the C-terminal end of TMS2 was located in the ribosomal tunnel
3 (2TML53K2163), 6 (2TML53K2166), or 11 (2TML53K2171) residues from the PTC.
When quenching experiments were performed using 2TML53K2163 (Fig.
18A), the nascent chain was exposed to the cytosol since maximal quenching
was observed with cytosolic iodide ions and the ΔKSV was very low (0.3 M
-1,
Table 4).  An equivalent result was obtained with 2TML12K2122 in that the probe
in this RNC was also exposed to the cytosol.
When the NBD fluorescence of 2TML53K2166 was monitored in the
presence of I- both before and after the addition of melittin, the nascent chain
was now found to be exposed to the lumen, not the cytosol (Fig. 18B).  The
observed ΔKSV of 2.2 M
-1 (Table 4) shows that maximal collisional quenching
was not observed until after MLT-dependent pore formation in the microsomal
membrane allowed the quencher entry into the lumen.  Similar results were
obtained when the nascent chain was extended in length by an additional 5
residues (Table 4, 2TML53K2171). These results were comparable to those
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Figure 18. Iodide ion quenching of long-loop integration intermediates.
Samples (A) 2TML53K2163 and (B) 2TML53K2166 were prepared and purified as
described in Ch. II. Iodide ion quenching was assessed using constant-ionic
strength procedures.  The membrane-bound integration intermediates were
examined both before ( ) and after ( ) the addition of MLT (5 µM final
concentration). The data shown are the average of 3-4 independent
experiments.
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obtained with corresponding short loop nascent chains (Table 5, 2TML12K2126
and 2TML12K2130) in terms of the nascent chain length dependence of the re-
establishment of the tight ribosome-translocon junction. Thus, despite the
additional length of nascent chain in the cytoplasmic domain of 2TML53K2, the
ion-tight seal formed by the ribosome at the cytoplasmic side of the translocon
pore is still formed only after the C-terminal end of TMS2 moves 4-7 residues
from the PTC.
Thus, several conclusions can be drawn.  First, the ribosome is able to
form and maintain an ion-tight seal with the translocon even after a large
cytoplasmic domain of the nascent chain has been synthesized. The details of
how the seal is maintained when a nascent chain strand extends into the cytosol
are not known at this time.  Second, it is the presence of a second TMS, not the
length of nascent chain, that elicits pore opening and closing.  Third, the
ribosome recognizes a TMS and initiates pore closing at the cytosolic and pore
opening at the lumenal end when the TMS is located only 4-7 residues away
from the PTC.
80
CHAPTER IV
SEQUENTIAL TRANSMEMBRANE SEGMENTS EFFECT
OPPOSITE CHANGES AT THE ER MEMBRANE
Does the Translocon Pore Alternately Open and Close
During MSMP Integration?
When the first TMS moves into the ribosomal tunnel, structural changes
are initiated at the membrane that result in the closure of the lumenal end and
the opening of the cytosolic end of the translocon pore, presumably to allow the
cytoplasmic domain of the nascent protein entry into the cytosol (Liao et al.,
1997).  When the second TMS moves into the ribosomal tunnel, this gating
mechanism is reversed to close the cytosolic end and open the lumenal end of
the pore.  Does the synthesis and movement of a third TMS down the ribosomal
tunnel trigger another reversal of pore closure (i.e., close the lumenal end and
open the cytosolic end), just as was seen with TMS1?  In other words, does the
translocon pore alternately open and close as sequential TMSs of a MSMP are
co-translationally integrated into the bilayer of the ER membrane, thereby
directing the newly synthesized lumenal and cytosolic domains of the protein
entry into their respective locations?
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The Ribosome-Translocon Junction Is Re-opened by a Third TMS
To determine the effect of a third TMS, a construct, 3TML12,17K3 (Fig. 10),
containing the third TMS from opsin, located 17 amino acids downstream from
TMS2, and a single lysine codon in TMS3.  Collisional quenching was then used
to examine integration intermediates with nascent chains truncated 3, 6, or 11
residues from the C-terminal end of TMS3, the same truncation sites used in the
previous TMS1 and TMS2 investigations.
We first looked at the state of the translocon when TMS3 was located 3
residues from the PTC, having a nascent chain length of 159 amino acids
residues.  Studies of TMS1 (Liao et al., 1997) and TMS2 (Ch. III) revealed that
pore opening/closing occurs after a TMS has moved 4-7 residues from the PTC.
If this pattern were to be repeated with TMS3, we would expect to see that the
ribosome is still engaged with the translocon when TMS3 is located only 3
residues from the PTC, and that the nascent chain would only be accessible to
lumenal iodide ions after the addition of MLT.  When I- was added to the cytosol,
the fluorescence intensity of the probe located in TMS3 was not maximally
quenched, therefore indicating that the nascent chain is not exposed to the
cytosol in this integration intermediate (Fig. 19A, Table 6).  After the quencher
was introduced into the lumen through MLT-induced pores, the nascent chain
was exposed to the lumen and the NBD fluorescence was quenched, yielding a
ΔKSV of 2.3 M
-1 (Table 6). Thus, the conformational changes at the membrane
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that were effected during the passage of TMS2 through the ribosomal tunnel
remained in effect immediately after the synthesis of TMS3.
Figure 19. Iodide ion quenching of integration intermediates containing 3
TMSs.  Samples (A) 3TML12,17K3159 and (B) 3TML12,17K3162 were prepared and
purified as described in Ch. II. Iodide ion quenching was assessed using
constant-ionic strength procedures.  The membrane-bound integration
intermediates were examined both before ( ) and after ( ) the addition of MLT
(5 µM final concentration). The data shown are the average of 3-4 independent
experiments.
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The KSV values shown are the average of 3-4 independent experiments. The
standard deviations for the KSV values were + 0.1-0.2 M
-1 except where
indicated.  Samples were prepared as described in Ch. II.
aThe standard deviations were + 0.3 M-1.
Table 6.  Iodide ion quenching of NBD-labeled MSMP integration
 intermediates containing three TMSs.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
3TML12,17K3159 1.9 4.2
a 2.3
3TML12,17K3162 4.1 4.1 0.0
3TML12,17K3167 4.2
a 4.4 0.2
3TML12,67K3209 2.0 4.1 2.1
3TML12,67K3212 3.9 4.1 0.2
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In contrast, when quenching experiments were performed with
3TML12,17K3162 (Fig. 19B), we found that cytosolic iodide ions were able to
access the nascent chain and maximally quench the fluorescence (Table 6).  In
order for the nascent chain to be exposed to the cytosol, the ribosome-
translocon junction must have re-opened because the probe was still located far
inside the ribosome tunnel and was not exposed to the cytosol when the nascent
chain was 159 residues long.  The nascent chain also remained exposed to the
cytosol as translation continued (Table 6, 3TML12,17K3167).
Movement of TMS1 into the ribosomal tunnel effected closure of the
lumenal end of the pore and also opened its cytosolic end (Liao et al., 1997).
The entry of TMS2 into the tunnel reversed the gating of the pore by opening the
lumenal end and re-forming the ribosome-translocon junction.  TMS3 initiated
the same changes at the membrane as TMS1.  Thus, the pore appears to be
alternately closed by lumenal BiP and the cytoplasmic ribosome as TMSs having
opposite orientations are cotranslationally moved through the ribosomal tunnel
and integrated into the ER membrane.
A Longer Nascent Chain Loop Between Adjoining TMSs Only Delays When
TMS3-Dependent Changes Occur at the Membrane
To determine what effect increasing the length of polypeptide between
TMS2 and TMS3 would have on structural changes at the membrane, we
repeated the collisional quenching experiments using construct 3TML12,67K3
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(Figure 10), that contains a 67-residue loop between TMS2 and TMS3 instead of
a 17-residue loop.
When the C-terminal end of TMS3 was 3 amino acids from the PTC, the
addition of iodide ions to a sample containing 3TML12,67K3209 integration
intermediates did not yield maximal quenching (Fig. 20A).  Since the quenching
was maximal only after the addition of MLT (Fig. 20A, Table 6), the NBD dyes
and nascent chains that were properly engaged at the membrane were exposed
to the lumen, not the cytosol.  Thus, even though TMS3 had been completely
synthesized and was present in the ribosomal nascent chain tunnel, no changes
had occurred at the membrane.  However, after an additional 3 amino acid
residues were synthesized (3TML12,67K3212, Fig. 20B), the nascent chain was
maximally quenched by I- and hence accessible to the cytosol, as shown by the
very low ΔKSV of 0.2 M
-1 (Table 6).
Thus, the longer loop between TMS2 and TMS3 only delayed the time at
which changes occurred at the membrane. These changes were triggered, as
with TMS1 and TMS2, by TMS3 moving into the ribosomal tunnel.  In fact, since
changes occur at the membrane only after the C-terminal end of a TMS (TMS1,
TMS2, TMS3) moves 4-7 residues from the PTC, it is clear that the important
polypeptide distance is that between the PTC and the TMS, not that between
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Figure 20. Iodide ion quenching of integration intermediates with a longer
TMS2-TMS3 loop.  Samples (A) 3TML12,67K3209 and (B) 3TML12,67K3212 were
prepared and purified as described in CHAPTER II. Iodide ion quenching was
assessed using constant-ionic strength procedures.  The membrane-bound
integration intermediates were examined both before ( ) and after ( ) the
addition of MLT (5 µM final concentration). The data shown are the average of 3
independent experiments.
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TMSs.  The length of the loop between adjacent TMSs does not appear to affect
the ribosome’s ability to recognize a TMS or to initiate conformational changes
at the membrane.
The ribosome therefore recognizes each TMS soon after it is synthesized
and moves into the ribosomal tunnel.  The passage of each TMS in turn elicits a
response that results in the alternate opening and closing of each end of the
aqueous translocon pore as the sequential TMSs of a MSMP are
cotranslationally integrated into the nonpolar core of the bilayer (Fig. 21). By
ensuring that one end of the translocon pore remains closed at any given time
during translation, the membrane is able to maintain its integrity and minimize
ion leakage from the lumen into the cytosol.
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Figure 21. Cotranslational integration of a MSMP into the ER membrane.
The translocon pore is alternately opened and closed as each sequential TMS of
a MSMP is synthesized and moves down the ribosomal tunnel into the
translocon.
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CHAPTER V
TRANSLOCON PORE OPENING AND
CLOSING IS TMS DEPENDENT
One Half of a TMS Is Not Sufficient to Elicit Changes at the Membrane
The data presented in the previous chapter demonstrate that the critical
structural feature for eliciting pore opening and closing is the presence of a TMS.
It therefore is appropriate to characterize further what structural features of the
TMS are recognized.
When quenching experiments were performed using a single-spanning
membrane protein that contained only the 10 N-terminal residues of the VSVG
TMS (TMS1), no quenching by cytosolic iodide ions was observed (Liao et al.,
1997). The ribosome was therefore able to distinguish between a complete TMS
and a partial TMS in regulating translocon gating.  To determine whether the
ribosome recognizes TMS2 in the same manner as TMS1, a fusion protein
identical to 2TML53K2 was prepared, except that the terminal 13 residues of
opsin TMS2 were deleted (Fig. 10).  This protein was designated 2TML53K1.5.  A
biochemical analysis of full length 2TML53K1.5 showed that the ribosome did not
recognize the remaining 10 amino acids as an intact TMS (Fig. 22).  TMS1 was
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Figure 22. The integration of 2TML53K1.5. The integration and orientation of
2TML53K1.5 in the membrane is shown.  Full length mRNA were translated in the
presence or absence of SRP and ER microsomes, then processed prior to SDS-
PAGE.  The protein is efficiently integrated into the membrane as shown by its
insolubility in alkaline buffer (pH 11.5) (compare lanes 4 and 5). It has an Nlum-
Ccyt orientation as shown by signal cleavage of the N-terminus (lane 2). The C-
terminus is located in the cytosol because there is no glycosylation of the
invertase domain (compare lanes 2 and 3).
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integrated into the bilayer in an Nlum-Ccyt orientation, as expected.  If the partial
TMS2 was recognized as a complete TMS and integrated into the membrane,
one would expect to see glycoslyation of the invertase domain. No glycoslyation
of the invertase domain was observed (compare lanes 2 and 3). Thus, the partial
TMS was not integrated into the membrane.
The quencher-dependent emission intensity of NBD was monitored for
nascent chain lengths of 163 and 171 amino acids using integration
intermediates of 2TML53K1.5.  Cytosolic iodide ions maximally quenched the
NBD fluorescence at both lengths (Table 7), thereby indicating that the nascent
chain is exposed to the cytosol when the nascent chain is 163 residues long
(Fig. 23A) and remains exposed to the cytosol as translation continues (Fig.
23B).  These results differ from those observed with a complete TMS2. Since
the ribosome-translocon junction was re-formed with 2TML53K2171, but not with
2TML53K1.5171, it appears that the ribosome is capable of differentiating between
hydrophobic stretches of nascent chain that are 10 or 23 residues long.
Furthermore, one half of a TMS is not sufficient to elicit the structural changes to
change the gating at the membrane.  Thus, ribosome recognition of a TMS
requires a certain number of nonpolar residues in sequence (this has not been
determined), and this is true for both the first and second TMSs through the
tunnel.
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The KSV values shown are the average of 2 independent experiments. The
errors for the KSV values were + 0.0-0.3 M
-1.  Samples were prepared as
described in Ch. II.
Table 7.  Iodide ion quenching of NBD-labeled  MSMP integration
 intermediates that contain an incomplete TMS.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
2TML53K1.5163 3.4 3.6 0.2
2TML53K1.5171 3.6 3.8 0.2
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Figure 23. Iodide ion quenching of integration intermediates containing a
nascent chain with a truncated TMS.  Samples (A) 2TML53K1.5163 and (B)
2TML53K1.5171 were prepared and purified as described in Ch. II. Iodide ion
quenching was assessed using constant-ionic strength procedures.  The
membrane-bound integration intermediates were examined both before ( ) and
after ( ) the addition of MLT (5 µM final concentration).  The data shown are the
average of 2 independent experiments.
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TMS Recognition by the Ribosome Is Independent of
Native Orientation in the Bilayer
In our membrane protein chimera, each TMS is inserted into the bilayer in
the same orientation (Ncyto or Nlum) as in the native proteins from which the TMSs
originate.  To determine if the ribosome can recognize the native orientation of a
TMS to determine how it gates the pore, the order of the TMSs in 2TML53K2 was
reversed to create a new chimeric protein, TM2 L53TM1, where the first TMS is
TMS2 from opsin and the second TMS is the single TMS in the VSVG protein
(Fig. 10). Even though the TMSs were not in their native orientation when TM2
L53TM1 was translated in the presence of SRP and ER microsomes, the protein
was integrated into the membrane in an N-lumenal/C-cytosol orientation as
determined by carbonate extraction and protease protection (Fig. 11). Thus, the
inversion of the TMSs did not alter the integration detected biochemically.
Does the movement of the first TMS through the ribosomal tunnel elicit
ribosome-translocon junction opening as was observed previously (Liao et al.,
1997)? By monitoring the emission intensity of a probe positioned in the first
TMS of TM2 L53TM191, we found that the nascent chain was initially protected
from cytosolic I- and exposed to lumenal I- (Fig. 24A, Table 8).  After the C-
terminal end of the TMS moved 6 residues away from the PTC (TM2 L53TM194),
fluorescence measurements showed that a change in the gating of the
translocon had taken place since the nascent chain probe was no longer
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Figure 24. Iodide ion quenching of integration intermediates with TMSs in
non-native orientations (part 1).  Samples (A) TM2L53TM1K191 and (B)
TM2L53TM1K194 were prepared and purified as described in Ch. II. Iodide ion
quenching was assessed using constant-ionic strength procedures.  The
membrane-bound integration intermediates were examined both before ( ) and
after ( ) the addition of MLT (5 µM final concentration). The data shown are the
average of 2 independent experiments.
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The KSV values shown are the average of 2 independent experiments. The
errors for the KSV values were + 0.0-0.2 M
-1 except where indicated.  Samples
were prepared as described in Ch. II.
aThe standard deviations were + 0.3-0.4 M-1.
Table 8.  Iodide ion quenching of NBD-labeled  MSMP integration
 intermediates having inverted TMSs.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
TM2L53TM191 1.1 3.4
a 2.3
TM2L53TM194 3.1
a 3.4 0.3
TM2L53TM1163 4.0 4.0 0.0
TM2L53TM1166 1.9 4.2 2.3
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protected from cytosolic I- (Fig. 24B, Table 8).  Thus, the synthesis and
movement of the first TMS resulted in closing the lumenal end and opening the
cytosolic end of the pore, thereby showing that the native orientation of the TMS
is not recognized by the ribosome.
Does the entry of a second TMS into the ribosomal tunnel reverse the
structural changes elicited by the first TMS, no matter what the native orientation
of the second TMS? After the second TMS was synthesized and located 3
residues from the PTC (TM2 L53TM1163, Fig. 25A), the ribosome-translocon
junction was still open because quenching by cytosolic I- was maximal before
the addition of MLT (Table 8).  After the second TMS had moved 6 residues
from the PTC (TM2 L53TM1166, Fig. 25B), cytosolic I
- no longer gave maximal
quenching and the ΔKSV was 2.3 M
-1 (Table 8).  Thus, the ion-tight ribosome-
translocon junction had reformed and properly-engaged nascent chains were no
longer exposed to the cytosol.
Since reversing the orientation of the VSVG TMS and the TMS2 from
opsin did not detectably affect the ribosome’s ability to recognize these TMSs,
and indicate the appropriate structural changes at the membrane, it appears that
the ribosome does not distinguish between TMSs based on their orientation in
the bilayer.  Instead, the ribosome appears to treat each sufficiently-long stretch
of nonpolar residues as a TMS and will alternate – by some as-yet undiscovered
mechanism – gating of the translocon pore.
98
Figure 25. Iodide ion quenching of integration intermediates with TMSs in
non-native orientations (part 2).  Samples (A) TM2L53TM1K2163 and (B)
TM2L53TM1K2166 were prepared and purified as described in Ch. II. Iodide ion
quenching was assessed using constant-ionic strength procedures.  The
membrane-bound integration intermediates were examined both before ( ) and
after ( ) the addition of MLT (5 µM final concentration). The data shown are the
average of 2 independent experiments.
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The Ribosome Recognizes and Elicits a Different Response When Two
Identical TMSs Are in a Series
The entry of a single VSVG TMS into the ribosomal tunnel effected
changes at the membrane in which the lumenal end of the translocon pore
closed and the cytosolic end opened (Liao et al., 1997). If the single TMS from
VSVG entered the tunnel a second time, in sequential order, would the ribosome
distinguish between the two identical TMSs?  If yes, does the ribosome treat the
identical TMSs as if they are two unique sequences by eliciting different
responses at the membrane as each sequential TMS enters the ribosomal
tunnel?
A chimeric protein, designated TM1L53TM1 (Fig. 10), was created by
replacing TMS2 from opsin in 2TML53K2 with the single TMS from VSVG. Thus,
the protein contains two VSVG TMSs; the first VSVG TMS maintaining its native
orientation (Nlum/Ccyt) and the second VSVG TMS being inverted. When
TM1L53TM1 was translated in the presence of SRP and ER microsomes, the
protein was integrated into the membrane in an N-lumenal/C-cytosol orientation
as determined by carbonate extraction and Endo H treatment (Fig. 11). A single
fluorescent probe was incorporated into the second TMS.
Collisional quenching experiments were performed using the TM1L53TM1
protein to address the aforementioned questions.  If the ribosome does indeed
distinguish between and treat identical TMSs as if they are two unique TMSs,
then the ribosome-translocon junction would be expected to re-form after the
100
second TMS entered the tunnel and moved at least 4 residues from the PTC,
based on the results obtained during the study of 2TML53K2 (Ch. III).
The emission intensity of TM1L53TM1 integration samples were monitored
when the C-terminal end of the second TMS was located 3 residues from the
PTC (TM1L53TM1159), and maximal quenching by cytosolic I
- was observed as
represented by the low ΔKSV of 0.1 M
-1 (Fig. 26A, Table 9).  The data suggest
that the seal between the ribosome and the translocon that was breached after
the first VSVG TMS moved through the tunnel remains so upon entry of the
second VSVG TMS into the tunnel.  However, after the second TMS moved an
additional 3 residues down the tunnel (TM1L53TM1162), so the TMS was now 6
residues from the PTC, maximal quenching by cytosolic I- was not observed.
Thus, the nascent chain was no longer exposed to cytosol (Fig. 26B). The
microsomes were then permeabilized by the addition of MLT, allowing the
introduction of I- into the lumen, and maximal quenching was observed as
represented by the ΔKSV of 2.1 M
-1 (Table 9). Therefore, a change in gating must
have taken place since the nascent chain is now protected from the cytosol.
The ribosome does indeed seem to recognize and differentiate between
two sequential VSVG TMSs, and the TMSs were treated as if they were two
unique sequences because the entry of each TMS into the ribosomal tunnel
generated a different response at the membrane.  When the first TMS moved
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The KSV values shown are the average of 2 independent experiments. The
errors for the KSV values were + 0.0-0.2 M
-1.  Samples were prepared as
described in Ch. II.
Table 9.  Iodide ion quenching of NBD-labeled  MSMP integration
 intermediates having identical TMSs.
Membrane Protein Observed KSV (M
-1) ΔKSV (M
-1)
-MLT +MLT
TM1L53TM1159 4.0 4.1 0.1
TM1L53TM1162 2.0 4.1 2.1
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Figure 26. Iodide ion quenching of TM1L53TM1K2 integration intermediates.
Samples (A) TM1L53TM1K2159 and (B) TM1L53TM1K2162 were prepared and
purified as described in Ch. II. Iodide ion quenching was assessed using
constant-ionic strength procedures and the averages from 2 independent
experiments are shown.  The membrane-bound integration intermediates were
examined both before ( ) and after ( ) the addition of MLT (5 µM final
concentration). The data shown are the average of 2 independent experiments.
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through the ribosomal tunnel, the lumenal end of the pore closed and the
cytosolic end opened (Liao et al., 1997).   Translocon gating was reversed when
the second TMS moved through the tunnel.  The cytosolic end of the pore
closed and lumenal end opened (Table 9). The results from these experiments
are in agreement with those obtained during the study of 2TML53K2 (Ch. III),
when two unique TMSs were present in the protein.  Therefore, the ribosome
does appear to differentiate between two adjacent TMSs having the same
sequence and elicits an appropriate response at the membrane to ensure that
the permeability barrier remains intact.
After studying the effects of native orientation and of identical TMS
sequences on the bilayer, several conclusions can be made. The ribosome
recognizes a nonpolar stretch of amino acids (19-23 residues in this study) as a
TMS and elicits an appropriate response based on the order that each TMS is
synthesized and enters the ribosomal tunnel.  A partial TMS containing only 10
nonpolar residues was not sufficient to initiate changes in pore opening and
closing. Reversing the orientation and order of the TMSs used in this study did
not appear to affect the translocon gating mechanism. The entry of a TMS into
the ribosomal tunnel seems to be the critical factor in eliciting changes at the
membrane.
104
CHAPTER VI
DISCUSSION AND SUMMARY
The purpose of a membrane is to form a barrier between two aqueous
compartments.  The endoplasmic reticulum (ER) membrane separates an
interior compartment, the lumen, from the surrounding cytoplasm.  Since the
lumen serves as a site of calcium ion storage in the cell, it is essential that the
permeability barrier of the ER membrane be maintained to prevent the
unregulated release of calcium ions.  Protein synthesis of multi-spanning
membrane proteins (MSMP) begins on free ribosomes located in the cytoplasm.
MSMPs have hydrophilic domains that are located on both sides of the
membrane as well as hydrophobic domains that need to be integrated into the
membrane. How, then, are these membrane proteins able to be cotranslationally
integrated into the bilayer of the ER membrane without disrupting the
permeability barrier and allowing unregulated release of ions?
The cotranslational integration of MSMPs into the ER membrane is a
highly regulated process involving extensive communication between the
ribosome synthesizing the protein and the translocon of the ER membrane.
During the cotranslational integration process it is the ribosome, not the
translocon, that first recognizes a transmembrane segment (TMS) and initiates a
series of conformational changes that occur at the ER membrane (Haigh and
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Johnson, 2002; Liao et al., 1997; Woolhead et al., 2004). The nascent
polypeptide is threaded into the aqueous translocon pore where each
successive TMS is moved laterally through the translocon into the nonpolar core
of the bilayer.  The hydrophilic polypeptide segments on each side of the TMS
are directed, alternatively, into either the aqueous cytosol or the aqueous lumen.
Here fluorescence spectroscopy was used to examine the process in
which the permeability barrier of the ER membrane is maintained during the
synthesis and subsequent integration of sequential TMSs of a MSMP.  We were
able to directly detect the exposure of the nascent chain to the cytosol and the
lumen by monitoring the fluorescence intensity of a probe incorporated into the
nascent chain.  By varying the lengths of nascent chain being studied, we were
able to examine and draw conclusions about the different stages of the
integration process.
It was found that the translocon pore alternately opens and closes as
sequential TMSs are synthesized and move into the ribosomal tunnel.  While the
first TMS through the tunnel caused the ribosome-translocon junction to open
(Haigh and Johnson, 2002; Liao et al., 1997), the second TMS elicited both the
closure of this junction and the opening of the lumenal end of the pore.  The
collisional quenching data show that when TMS2 first entered the ribosomal
tunnel, the ribosome did not immediately recognize the nascent polypeptide as a
second TMS, and maximal quenching by cytosolic I- was observed
(2TML12K2122).  However, after the C-terminal end of TMS2 had moved 7
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residues from the PTC, changes at the membrane had occurred. The ribosome-
translocon junction was reformed and the lumenal end of the translocon pore
was opened, as shown by the maximal quenching of lumenal I- (2TML12K2126).
Thus, the ribosome recognizes a newly synthesized TMS and effects changes at
the membrane early on during translation, when the TMS is located just 4-7
residues from the PTC.
The synthesis and entry of a third TMS into the ribosomal tunnel reversed
the changes that had occurred at the membrane during the synthesis of TMS2.
The nascent chain remained protected from the cytosol after TMS3 had entered
the tunnel and was located 3 residues from the PTC (3TML12,17K3159).  After
TMS3 moved an additional 3 residues from the PTC, the nascent chain was no
longer protected from the cytosol because maximal quenching by cytosolic I-
was observed (3TML12,17K3162).
The presence of a TMS appears to be the critical factor in effecting pore
opening/closing.  When only one half of a TMS was present (2TML53K1.5), the
ribosome did not recognize the 10 residue hydrophobic stretch as a TMS and
did not initiate the integration progress.  The ribosome also did not distinguish
between TMSs based on their orientation in the bilayer (TM2L53TM1).  When two
identical TMSs were synthesized in series (TM1L53TM1), the ribosome identified
each stretch of hydrophobic amino acids as a TMS and elicited a different
response based on their order of entry into the tunnel.  Therefore, the ribosome
seems to effect alternating pore closure when a sufficiently-long stretch of
107
hydrophobic amino acids, recognized as a TMS, is synthesized and moves
down the ribosomal tunnel.
The changes effected at the translocon by the synthesis of multiple TMSs
do not correlate with nascent chain length.  Increasing the length of the nascent
chain loop between adjacent TMSs (2TML53K2 and 3TML12,67K3) did not alter the
pattern observed.  When each newly synthesized TMS had entered the tunnel
and was located 4-7 residues from the PTC, changes in translocon gating
occurred.  Therefore, it is most likely the position of the TMS inside the
ribosome, not the length of nascent chain, that elicits pore opening/closing.
Liao et al. (Liao et al., 1997) hypothesized that the ribosome may
recognize a TMS when a weakly nonpolar patch in the ribosomal tunnel
nucleates the folding of a hydrophobic TMS into an α-helix.  To address this
hypothesis, FRET experiments were performed using a protein containing a
single TMS.  The results showed that the TMS does fold into an α-helix, or
nearly so, while far inside the ribosomal tunnel (Woolhead et al., 2004). No
folding was observed when the nascent chain lacked a TMS, or when, in the
absence of microsomes, the TMS was located outside of the ribosome (Lin,
unpublished data; Woolhead et al., 2004).  FRET experiments have since been
performed with the MSMPs used in the collisional quenching studies described
in this dissertation (Lin, unpublished data), and it was found that the changes
observed in translocon gating exactly coincided with ribosome-induced TMS
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folding. Thus, nascent chain folding and binding far inside the tunnel control
ribosome-translocon interactions at the ER membrane.
The data obtained studying MSMPs containing 2 and 3 TMSs reveal that
the synthesis and movement of sequential TMSs into the ribosomal tunnel elicit
changes at the membrane that cause the translocon pore to alternately open
and close.  These observations seem reasonable because the MSMPs contain
alternating aqueous lumenal and cytoplasmic domains that need to be directed
into the lumen and cytoplasm respectively.  The integrity of the ER membrane is
maintained during the cotranslational integration of MSMPs by ensuring that one
end of the translocon pore remains sealed at any given time. The data reveal
that cotranslational integration of a MSMP is a well choreographed and precisely
timed event necessary to maintain the integrity of the ER membrane.
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